https://www.lmi.no/2025/02/06/slik-skal-dmp-fa-ned-saksbehandlingstiden-for-metodevurderinger/ 2025-02-06T11:18:57+00:00 https://www.lmi.no/2025/02/06/omsetningen-av-semaglutid-okte-med-14-milliarder-kroner/ 2025-02-06T11:19:39+00:00 https://www.lmi.no/2025/02/06/bruken-av-reseptpliktige-legemidler-har-okt/ 2025-02-06T11:20:46+00:00 https://www.lmi.no/2025/02/06/avviser-at-dmp-vurderer-habilitet-strengt-vi-kan-ikke-vaere-mye-mer-liberale-enn-andre-land/ 2025-02-06T11:22:13+00:00 https://www.lmi.no/2025/02/06/dmp-stiller-nye-krav-til-industrien/ 2025-02-06T11:23:20+00:00 https://www.lmi.no/2025/02/06/nortrials-sentrene-inviterer-til-digitale-informasjonsmoter/ 2025-02-06T13:38:38+00:00 https://www.lmi.no/wp-content/uploads/2022/06/chris-montgomery-smgTvepind4-unsplash-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/chris-montgomery-smgTvepind4-unsplash-2-scaled.jpg https://www.lmi.no/2025/02/07/norge-pa-krefttoppen-en-ting-gir-hap/ 2025-02-07T09:51:40+00:00 https://www.lmi.no/2025/02/07/studie-nye-legemidler-fortrenger-mer-helse-enn-de-genererer/ 2025-02-07T09:55:04+00:00 https://www.lmi.no/2025/02/07/har-ikke-konkludert-etter-ekstern-granskning-av-israelsk-legemiddelselskap/ 2025-02-07T09:56:27+00:00 https://www.lmi.no/2025/02/07/ny-runde-med-kutt-i-bms-skal-spare-inn-to-milliarder-dollar/ 2025-02-07T09:57:41+00:00 https://www.lmi.no/2025/02/07/eli-lilly-tjente-mer-penger-enn-forventet/ 2025-02-07T09:58:40+00:00 https://www.lmi.no/2025/02/07/astrazeneca-far-mindre-bot-enn-fryktet/ 2025-02-07T10:00:58+00:00 https://www.lmi.no/2025/02/07/brukte-for-mye-nesespray-burde-aldri-vaert-operert/ 2025-02-07T10:05:02+00:00 https://www.lmi.no/2025/02/07/kina-sporsmal-kan-overskygge-resultater-nar-astrazeneca-legger-frem-kvartalstall/ 2025-02-07T10:11:33+00:00 https://www.lmi.no/2025/02/07/medlemsmotet-i-opptak-2/ 2025-02-07T12:44:29+00:00 https://www.lmi.no/wp-content/uploads/2025/02/front-medlemsm-kopi.jpg https://www.lmi.no/2025/02/07/inviterer-industrien-til-a-gjore-studier-med-hjelp-av-metabolomikk/ 2025-02-10T08:09:31+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Katja-og-Helge-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/Katja-og-Helge-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/Bloddrapeark-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/Katja-pipetterer-1-scaled.jpg https://www.lmi.no/2025/02/10/norges-nye-medisinsjef-vil-ha-raskere-metodevurderinger-og-bedre-beredskap/ 2025-02-10T12:29:25+00:00 https://www.lmi.no/2025/02/10/700-000-nordmenn-avhengig-av-nesespray-ifolge-ny-undersokelse/ 2025-02-10T12:30:47+00:00 https://www.lmi.no/2025/02/10/boter-milliardkutt-og-salgsrekorder-slik-var-legemiddelselskapenes-resultatslipp/ 2025-02-10T12:32:26+00:00 https://www.lmi.no/2025/02/10/norge-i-krefttoppen-i-europa-40-prosent-rammes-for-de-er-80-ar/ 2025-02-10T12:33:21+00:00 https://www.lmi.no/2025/02/10/oncoinvent-henter-11-millioner-kroner-i-emisjon/ 2025-02-10T12:34:17+00:00 https://www.lmi.no/2025/02/10/dette-skal-beslutningsforum-ta-stilling-til-i-februar/ 2025-02-10T12:35:12+00:00 https://www.lmi.no/2025/02/10/novo-nordisk-med-forelopige-nyheter-fra-studie-hemofilimedisin-tolereres-godt-hos-barn/ 2025-02-10T12:36:09+00:00 https://www.lmi.no/2025/02/10/sannsynlig-innforing-av-immunterapi-mot-livmorkreft-pa-mandag/ 2025-02-10T12:40:51+00:00 https://www.lmi.no/2025/02/10/jobber-med-fremtidens-vaksine-testet-i-over-20-ar/ 2025-02-10T12:41:42+00:00 https://www.lmi.no/2025/02/10/kjente-legemidler-kan-fa-fart-pa-demensforskning/ 2025-02-10T12:42:41+00:00 https://www.lmi.no/2025/02/10/dette-skjer-i-uke-7-helseministeren-til-bergen-og-ap-mot-sp-i-sporretimen/ 2025-02-10T12:43:33+00:00 https://www.lmi.no/2025/02/10/dmp-skjerper-krav-til-innlevering-av-dokumentasjon/ 2025-02-10T12:45:02+00:00 https://www.lmi.no/2025/02/10/fda-bremser-utprovingen-av-amgens-fedmekandidat/ 2025-02-10T12:45:51+00:00 https://www.lmi.no/2025/02/07/alt-klart-for-norway-life-science-2025/ 2025-02-10T13:50:27+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Banner-front-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/02/banner_hovedbanner-nettside_1200x514_engelsk-kopi.jpg https://www.lmi.no/2025/02/11/fremragende-forskning-pa-kunstig-intelligens-og-helsedata-baner-vei-for-fremtidens-helse/ 2025-02-11T09:13:39+00:00 https://www.lmi.no/2025/02/11/jubler-etter-ja-dette-gir-hap/ 2025-02-11T09:14:26+00:00 https://www.lmi.no/2025/02/11/etter-to-avslag-beslutningsforum-sier-ja-til-behandling-av-kronisk-lymfatisk-leukemi/ 2025-02-11T09:15:19+00:00 https://www.lmi.no/2025/02/11/beslutningsforum-innforer-nye-kreftbehandlinger/ 2025-02-11T09:16:08+00:00 https://www.lmi.no/2025/02/11/fersk-pulsmaling-av-helseindustrien-fremdeles-langt-fra-eksportmalet-til-tross-for-vekst/ 2025-02-11T09:17:14+00:00 https://www.lmi.no/2025/02/11/trump-vurderer-toll-pa-legemidler/ 2025-02-11T09:18:12+00:00 https://www.lmi.no/2025/02/11/tydelig-fotavtrykk-pa-norway-life-science-2025/ 2025-02-11T18:12:11+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Norway-Life-Science-2025-Solberg-Thomassen-Akay-og-Tasken-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/Norway-Life-Science-2025-Solberg-Thomassen-Akay-og-Tasken-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/AstraZenecas-Stefan-Woxstrom.jpg https://www.lmi.no/2025/02/12/lmi-i-dagens-medisin-har-metodevurderinger-skadet-folkehelsen-i-storbritannia/ 2025-02-12T08:45:49+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Kronikk-Jens-om-Lancet.png https://www.lmi.no/wp-content/uploads/2025/02/Kronikk-Jens-om-Lancet.png https://www.lmi.no/2025/02/12/astrazenecas-sjef-for-europa-og-canada-derfor-har-jeg-hap-for-norge/ 2025-02-12T09:44:40+00:00 https://www.lmi.no/2025/02/12/astrazeneca-topp-se-til-danmark-og-sverige/ 2025-02-12T09:46:01+00:00 https://www.lmi.no/2025/02/12/eksportvekst-i-helseindustrien-men-produksjon-og-innovasjon-svekkes/ 2025-02-12T09:46:54+00:00 https://www.lmi.no/2025/02/12/ous-direktoren-kaller-helsedata-gullegg-men-vi-er-darlige-pa-klekking/ 2025-02-12T09:47:47+00:00 https://www.lmi.no/2025/02/12/advarer-mot-hjerneflukt-i-helseindustrien/ 2025-02-12T09:48:49+00:00 https://www.lmi.no/2025/02/12/lover-norsk-life-science-strategi-dersom-hoyre-far-makten/ 2025-02-12T09:49:47+00:00 https://www.lmi.no/2025/02/12/nye-langtidsdata-for-bayers-oyemedisin/ 2025-02-12T09:50:34+00:00 https://www.lmi.no/2025/02/12/astrazeneca-topp-ser-hap-i-helsedata/ 2025-02-12T09:51:26+00:00 https://www.lmi.no/2025/02/11/ny-rapport-viser-behovet-for-en-norsk-life-science-strategi/ 2025-02-12T13:49:13+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Norway-Life-Science-2025_Menon.jpg https://www.lmi.no/wp-content/uploads/2025/02/Norway-Life-Science-2025_Menon.jpg https://www.lmi.no/2025/02/13/rapport-helseindustrien-har-blitt-mindre-lonnsom/ 2025-02-13T08:22:12+00:00 https://www.lmi.no/2025/02/13/nho-topper-kaller-vestre-for-pratmaker/ 2025-02-13T08:23:13+00:00 https://www.lmi.no/2025/02/13/oppsiktsvekkende-teori-forskere-kan-ha-funnet-arsaken-til-alzheimer/ 2025-02-13T08:24:33+00:00 https://www.lmi.no/2025/02/13/usa-godkjenner-ny-smertestillende-medisin-som-ikke-skal-gjore-folk-avhengige/ 2025-02-13T08:25:31+00:00 https://www.lmi.no/2025/02/13/biogen-solgte-alzheimerlegemiddel-for-nesten-en-milliard-kroner-i-fjerde-kvartal/ 2025-02-13T08:29:18+00:00 https://www.lmi.no/2025/02/13/mange-nordmenn-er-avhengig-skremmende/ 2025-02-13T08:31:41+00:00 https://www.lmi.no/2025/02/13/lytix-bioharma-far-tommel-opp-for-patent-i-usa/ 2025-02-13T08:39:35+00:00 https://www.lmi.no/2025/02/13/lmi-sjefen-svarer-dmp-sjefen-skjonner-ikke-hva-selskapene-skal-tjene-pa-det/ 2025-02-13T08:43:08+00:00 https://www.lmi.no/2025/02/12/nls25-velferdsteknologi-ingeniorer-og-apne-dorer-kan-lose-mye/ 2025-02-13T11:14:59+00:00 https://www.lmi.no/wp-content/uploads/2025/02/NLS25_dag-2-panel-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/NLS25_dag-2-panel-scaled.jpg https://www.lmi.no/2025/02/13/healthtalk-lmi-sjefen-svarer-dmp-sjefen/ 2025-02-13T12:20:41+00:00 https://www.lmi.no/wp-content/uploads/2025/02/HealthTalk-LeifRune-13.02.25.png https://www.lmi.no/wp-content/uploads/2025/02/HealthTalk-LeifRune-13.02.25.png https://www.lmi.no/2025/02/13/arrangerte-introduksjonsmote-for-den-nye-dmp-sjefen/ 2025-02-13T13:03:40+00:00 https://www.lmi.no/wp-content/uploads/2025/02/IMG_4663-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/IMG_4669-scaled.jpg https://www.lmi.no/2025/02/13/nls25-norge-trenger-en-life-science-strategi-for-a-oke-konkurransekraften/ 2025-02-14T09:33:37+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Norway-Life-Science-2025-Jensen-Stensland-Niederbach-Skymoen-Kreutzer-Stolen-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/02/Norway-Life-Science-2025-Jensen-Stensland-Niederbach-Skymoen-Kreutzer-Stolen-scaled.jpg https://www.lmi.no/2025/02/14/michael-vester-om-lmi-sjefen-fremsetter-regelmessig-alternative-sannheter/ 2025-02-14T10:32:33+00:00 https://www.lmi.no/2025/02/14/krever-fortgang-i-helseforhandlinger-med-eu-skilsmissen-er-pa-plass/ 2025-02-14T10:33:40+00:00 https://www.lmi.no/2025/02/14/norge-har-unike-helsedata-men-hvordan-utnytte-dem/ 2025-02-14T10:35:11+00:00 https://www.lmi.no/2025/02/14/debatt-prioriteringsmeldingen-bor-utsettes-til-etter-valget/ 2025-02-14T10:36:07+00:00 https://www.lmi.no/2025/02/14/astrazeneca-etterlyser-umiddelbar-tilgang-til-helsedata-da-er-vi-villige-til-a-investere/ 2025-02-14T10:36:56+00:00 https://www.lmi.no/2025/02/14/lytix-biopharma-er-godt-skodd-med-kontanter/ 2025-02-14T10:38:03+00:00 https://www.lmi.no/2025/02/14/hoyre-fremmer-forslag-om-life-science-strategi-ap-sier-nei/ 2025-02-14T13:06:03+00:00 https://www.lmi.no/wp-content/uploads/2018/05/Stensland.jpg https://www.lmi.no/wp-content/uploads/2018/05/Stensland.jpg https://www.lmi.no/2025/02/17/kronikk-peker-eus-konkurransekompass-mot-nord/ 2025-02-17T11:25:20+00:00 https://www.lmi.no/wp-content/uploads/2025/02/kronikk-E24-2.png https://www.lmi.no/wp-content/uploads/2025/02/Kronikk-E24.png https://www.lmi.no/2025/02/17/mener-ny-kreftstrategi-mangler-tiltak-for-raskere-tilgang-til-kreftmedisiner/ 2025-02-17T11:45:52+00:00 https://www.lmi.no/2025/02/17/helsekoene-oker-%e2%81%a0-helt-uakseptabelt/ 2025-02-17T11:46:38+00:00 https://www.lmi.no/2025/02/17/reagerer-pa-vestres-royke-tiltak-politikken-trumfer-vitenskapen/ 2025-02-17T11:47:47+00:00 https://www.lmi.no/2025/02/17/sanofi-og-johnson-johnson-avbryter-senfase-studie-om-eksperimentell-e-coli-vaksine/ 2025-02-17T11:49:11+00:00 https://www.lmi.no/2025/02/17/debatt-peker-eus-konkurransekompass-mot-nord/ 2025-02-17T11:52:07+00:00 https://www.lmi.no/2025/02/17/i-enkelte-tilfeller-kan-nesen-falle-sammen/ 2025-02-17T11:53:02+00:00 https://www.lmi.no/2025/02/17/ny-studie-tidlig-varselsignal-for-sykdommen/ 2025-02-17T11:53:55+00:00 https://www.lmi.no/2025/02/17/sier-nei-til-norsk-livsvitenskapsstrategi-lover-ikke-godt-for-bransjen/ 2025-02-17T11:56:31+00:00 https://www.lmi.no/2025/02/18/trump-kutt-kan-hemme-robert-f-kennedy-jr-og-hans-lange-liste-over-gjoremal/ 2025-02-18T10:46:37+00:00 https://www.lmi.no/2025/02/18/legemiddeltopper-skal-trolig-mote-trump-denne-uken/ 2025-02-18T10:48:05+00:00 https://www.lmi.no/2025/02/18/novo-nordisks-toppledelse-pa-sjarm-tur-for-a-berolige-investorer-og-analytikere/ 2025-02-18T10:55:37+00:00 https://www.lmi.no/2025/02/18/lmi-har-fatt-gjennomslag-i-tildelingsbrevet-til-dmp/ 2025-02-18T12:14:44+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Thordis-Widvey-Haugen-6012-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Thordis-Widvey-Haugen-6012-scaled.jpg https://www.lmi.no/2025/02/20/sykehusinnkjop-matte-avlyse-anbud-brot-anbudsregel-i-telefonsamtale/ 2025-02-20T10:58:46+00:00 https://www.lmi.no/2025/02/20/god-grunn-til-oppmerksomhet-om-at-det-kan-skape-uheldige-bindinger/ 2025-02-20T13:15:46+00:00 https://www.lmi.no/2025/02/20/bavarian-nordic-far-chikungunya-vaksine-godkjent-i-usa/ 2025-02-20T13:17:20+00:00 https://www.lmi.no/2025/02/20/kraftig-vekst-i-bruken-av-adhd-medisiner/ 2025-02-20T13:18:11+00:00 https://www.lmi.no/2025/02/20/salget-av-alzheimer-legemiddel-har-nadd-200-millioner-euro/ 2025-02-20T13:19:31+00:00 https://www.lmi.no/2025/02/20/fda-ansatte-som-skulle-vurdere-neuralinks-hjerneimplantat-har-fatt-sparken-av-musks-jobbelimineringsskvadron/ 2025-02-20T13:21:22+00:00 https://www.lmi.no/2025/02/20/kreftforeningen-investerer-millioner-i-legemidler-satser-pa-ny-kreftbehandling/ 2025-02-20T13:22:34+00:00 https://www.lmi.no/2025/02/20/donald-trump-vil-ha-25-prosent-toll-pa-medisiner/ 2025-02-20T13:23:23+00:00 https://www.lmi.no/2025/02/20/kvinnehelseselskap-med-norsk-venture-i-ryggen-hentet-316-millioner-kroner/ 2025-02-20T13:24:41+00:00 https://www.lmi.no/2025/02/20/photocure-omsatte-for-naer-en-halv-milliard-kroner-i-2024/ 2025-02-20T13:25:42+00:00 https://www.lmi.no/2025/02/20/storbank-novo-nordisk-mister-markedsandeler-i-usa/ 2025-02-20T13:26:46+00:00 https://www.lmi.no/2025/02/20/lmi-kritisk-til-kreftstrategien/ 2025-02-20T13:27:43+00:00 https://www.lmi.no/2025/02/20/pfizers-toppsjef-etter-tolltrusler-vi-er-sarbare/ 2025-02-20T13:28:51+00:00 https://www.lmi.no/2025/02/20/mange-norske-pasienter-i-global-lungekreft-studie-banebrytende/ 2025-02-20T13:29:52+00:00 https://www.lmi.no/2025/02/20/nye-kreftlegemidler-ma-bli-raskere-tilgjengelige/ 2025-02-20T13:55:29+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/2025/02/21/faller-pa-sin-egen-urimelighet/ 2025-02-21T11:32:59+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Vestre.png https://www.lmi.no/wp-content/uploads/2025/02/Vestre.png https://www.lmi.no/2025/02/21/na-innfores-nye-legemidler-raskere-i-norske-sykehus/ 2025-02-21T11:48:19+00:00 https://www.lmi.no/2025/02/21/helseindustrien-far-ikke-flytte-inn-i-det-nye-livsvitenskapsbygget-vi-ma-ikke-se-oss-blinde-pa-dette-ene-bygget/ 2025-02-21T11:49:28+00:00 https://www.lmi.no/2025/02/24/stor-oversikt-61-fordeler-og-ulemper-med-slankemedisin/ 2025-02-24T09:24:17+00:00 https://www.lmi.no/2025/02/24/eli-lilly-fyller-opp-lager-av-fedmemedisin-ett-ar-for-lansering/ 2025-02-24T09:25:15+00:00 https://www.lmi.no/2025/02/24/vil-du-dele-helsedataene-dine-for-a-trene-opp-en-kunstig-intelligens/ 2025-02-24T09:27:47+00:00 https://www.lmi.no/2025/02/24/studie-omega-3-tilskudd-reduserte-den-biologiske-aldringen/ 2025-02-24T09:28:42+00:00 https://www.lmi.no/2025/02/24/for-30-ar-siden-fantes-ingen-behandling-for-sykdommen-sara-louise-fikk-som-17-aring/ 2025-02-24T09:33:36+00:00 https://www.lmi.no/2025/02/24/endelig-har-torstein-lerhol-38-fatt-forste-dose-spinraza-jeg-er-nesten-sistemann-ut/ 2025-02-24T09:39:42+00:00 https://www.lmi.no/2025/02/24/norske-pasienter-ventet-lenger-pa-nye-legemidler-i-2024-enn-i-2021-lmi-kommenterer/ 2025-02-24T09:48:17+00:00 https://www.lmi.no/2025/02/24/har-kuttet-saksbehandlingstiden-tross-lengre-ventetid-pa-dokumentasjon-fra-industrien/ 2025-02-24T09:49:34+00:00 https://www.lmi.no/2025/02/25/referat-fra-kontaktmote-mellom-lmi-og-hod/ 2025-02-25T08:25:12+00:00 https://www.lmi.no/wp-content/uploads/2023/03/hodbygget_315x177-1.webp https://www.lmi.no/wp-content/uploads/2023/03/hodbygget_315x177-1.webp https://www.lmi.no/2025/02/26/biotekselskapet-bergenbio-avbryter-hovedstudie/ 2025-02-26T13:06:00+00:00 https://www.lmi.no/2025/02/26/bergenbio-skroter-hovedstudie-vurderer-salg-eller-fusjon/ 2025-02-26T13:06:30+00:00 https://www.lmi.no/2025/02/26/bergenbio-satset-alt-mislyktes-med-hovedstudien/ 2025-02-26T13:06:52+00:00 https://www.lmi.no/2025/02/26/pfizer-henter-nylig-avgatt-fda-leder-som-medisinsk-direktor/ 2025-02-26T13:09:30+00:00 https://www.lmi.no/2025/02/26/demens-anslatt-a-koste-norge-100-milliarder-i-2050-en-dobling-fra-2022/ 2025-02-26T13:13:27+00:00 https://www.lmi.no/2025/02/26/permitterte-halvparten-av-de-ansatte-og-stanset-produksjonen-avhengig-av-nye-markeder/ 2025-02-26T13:17:08+00:00 https://www.lmi.no/2025/02/26/curida-styrelederen-helsekatapult-er-langt-fra-nok/ 2025-02-26T13:18:42+00:00 https://www.lmi.no/2025/02/26/nykode-grunderen-ser-okt-aktivitet-i-markedet-for-kreftvaksiner/ 2025-02-26T13:21:54+00:00 https://www.lmi.no/2025/02/28/tidenes-verste-borsdag-for-bergenbio/ 2025-02-28T11:29:21+00:00 https://www.lmi.no/2025/02/28/trump-vil-innfore-eu-toll-pa-25-prosent/ 2025-02-28T11:31:22+00:00 https://www.lmi.no/2025/02/28/trond-mohn-synes-synd-pa-smaaksjonaerene-i-bergenbio/ 2025-02-28T11:32:40+00:00 https://www.lmi.no/2025/02/28/antibiotikabruken-oker-janne-ble-smittet-av-resistente-bakterier/ 2025-02-28T11:33:31+00:00 https://www.lmi.no/2025/02/28/debatt-et-likeverdig-behandlingstilbud-ma-vaere-mer-enn-gode-intensjoner/ 2025-02-28T11:35:36+00:00 https://www.lmi.no/2025/02/28/kronikk-sjelden-men-ikke-glemt-hva-kan-vi-fa-til-sammen/ 2025-02-28T11:36:28+00:00 https://www.lmi.no/wp-content/uploads/2025/02/Skjermdump_dm_kronikk-sjeldendagen-25.png https://www.lmi.no/wp-content/uploads/2025/02/Skjermdump_dm_kronikk-sjeldendagen-25.png https://www.lmi.no/2025/02/28/lmi-mener-sykehusinnkjop-tar-feil-i-foring-av-tidsbruk/ 2025-02-28T11:36:29+00:00 https://www.lmi.no/2025/02/28/patent-milepael-for-pluvia/ 2025-02-28T11:37:26+00:00 https://www.lmi.no/2025/02/28/arctic-bioscience-ser-tre-mulige-retninger-for-legemiddelkandidat/ 2025-02-28T11:38:16+00:00 https://www.lmi.no/2025/02/28/debatt-sjelden-men-ikke-glemt-hva-kan-vi-fa-til-sammen/ 2025-02-28T11:40:35+00:00 https://www.lmi.no/2025/03/03/toppmote-pharma-sjefenes-aerlige-mening-om-den-nye-dmp-sjefen/ 2025-03-03T07:31:11+00:00 https://www.lmi.no/2025/03/03/debatt-veikart-for-helsenaering-fra-festtaler-til-handling-na/ 2025-03-03T07:32:13+00:00 https://www.lmi.no/2025/03/03/chmp-fire-nye-legemidler-anbefales-godkjent-i-europa/ 2025-03-03T07:33:07+00:00 https://www.lmi.no/2025/03/03/blodkreft-leger-haper-kll-ja-kan-apne-for-nye-medisiner-i-fremtiden/ 2025-03-03T07:34:19+00:00 https://www.lmi.no/2025/03/03/oppsiktsvekkende-kreft-funn-okt-overlevelse/ 2025-03-03T07:35:13+00:00 https://www.lmi.no/2025/03/03/ny-smertestillende-lover-ingen-risiko/ 2025-03-03T07:36:19+00:00 https://www.lmi.no/2025/03/03/ny-ikke-opioid-smertebehandling-godkjent-i-usa/ 2025-03-03T09:51:07+00:00 https://www.lmi.no/2025/03/03/helge-lund-og-resten-av-novo-styret-foreslas-gjenvalgt/ 2025-03-03T09:52:13+00:00 https://www.lmi.no/2025/03/03/dmps-nye-leder-motte-industrien/ 2025-03-03T10:27:53+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Trygve-Ottersen-1.jpg https://www.lmi.no/wp-content/uploads/2025/03/Trygve-Ottersen-og-Leif-Rune-Skymoen-scaled.jpg https://www.lmi.no/2025/03/05/klimahensyn-bor-inkluderes-i-bytteordningen-for-legemidler/ 2025-03-05T10:43:32+00:00 https://www.lmi.no/2025/03/05/casper-lorentzen-er-ny-journalist-i-healthtalk/ 2025-03-05T10:44:25+00:00 https://www.lmi.no/2025/03/05/ord-duell-om-helsekoeneet-politisk-fluepapir/ 2025-03-05T10:45:39+00:00 https://www.lmi.no/2025/03/05/ema-far-opp-farten-pa-vurderingen-av-gileads-hiv-behandling/ 2025-03-05T10:49:06+00:00 https://www.lmi.no/2025/03/05/australia-vender-tommelen-ned-for-alzheimer-legemiddel/ 2025-03-05T10:49:53+00:00 https://www.lmi.no/2025/03/05/lmi-onsker-mer-europeisk-samarbeid-og-nasjonal-produksjon/ 2025-03-05T10:50:45+00:00 https://www.lmi.no/2025/03/05/dmp-supersatser-pa-beredskap-og-mangel/ 2025-03-05T10:51:36+00:00 https://www.lmi.no/2025/03/05/vi-kunne-fjernet-skatt-pa-arbeid-for-alle-med-inntekt-under-en-million-kroner/ 2025-03-05T10:52:31+00:00 https://www.lmi.no/2025/03/05/danmark-innforer-verzenios-for-brystkreft-etter-nye-data-og-lavere-pris/ 2025-03-05T10:53:18+00:00 https://www.lmi.no/2025/03/05/novo-nordisk-inngar-partnerskap-med-ki-biotekselskap/ 2025-03-05T10:54:02+00:00 https://www.lmi.no/2024/10/22/kliniske-studier-i-eos-taper-terreng/ 2025-03-05T10:55:43+00:00 https://www.lmi.no/wp-content/uploads/2024/10/Efpia-rapportHelsedata.png https://www.lmi.no/wp-content/uploads/2024/10/Efpia-rapportHelsedata.png https://www.lmi.no/2025/03/04/syklotronsenteret-utvider-bygger-fabrikk-for-medisinske-isotoper/ 2025-03-05T15:22:05+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Syklotronsenteret-FoU-avdeling-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Thor-Audun-Saga-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Syklotronsenteret-FoU-avdeling-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Syklotronsenteret-kontrollrom-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Syklotronsenteret-kontorlokalene-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/IMG_6654-%E2%80%93-Kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/IMG_6655-%E2%80%93-Kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Syklotronsenteret-sikkerhetsluke-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Syklotronsenteret-Gruppebilde-i-trappa-scaled.jpg https://www.lmi.no/2025/03/10/efpia-varsler-rettslige-skritt-mot-nytt-eu-regelverk/ 2025-03-10T10:17:51+00:00 https://www.lmi.no/2025/03/10/novo-nordisk-vil-undersoke-bruk-av-glp-1-midler-til-behandling-av-avhengighet/ 2025-03-10T10:19:11+00:00 https://www.lmi.no/2025/03/10/generika-kjempe-advarer-mot-trump-toll-mener-prisene-vil-ga-til-vaers/ 2025-03-10T10:20:06+00:00 https://www.lmi.no/2025/03/10/enhertu-anbefalt-for-godkjenning-i-europa-for-her2-lav-og-her2-ultralav-brystkreft/ 2025-03-10T10:21:11+00:00 https://www.lmi.no/2025/03/10/slar-alarm-om-helsefunn-blant-unge-kvinner-ma-tas-pa-alvor/ 2025-03-10T10:22:04+00:00 https://www.lmi.no/2025/03/10/nykode-mener-data-fra-konkurrent-kan-lette-partnerjakten/ 2025-03-10T10:29:26+00:00 https://www.lmi.no/2025/03/10/faerre-har-fedme-i-usa-handler-det-virkelig-om-slankemedisinene/ 2025-03-10T10:30:50+00:00 https://www.lmi.no/2025/03/10/medisinske-mirakler-har-aldri-kommet-av-seg-selv/ 2025-03-10T10:32:02+00:00 https://www.lmi.no/2025/03/10/overrasket-over-nei-til-lavere-pris-ved-rask-innforing-av-immunterapi/ 2025-03-10T10:33:08+00:00 https://www.lmi.no/2025/03/10/danskene-endrer-myelomatose-anbefaling-dette-sier-norsk-ekspert/ 2025-03-10T10:34:14+00:00 https://www.lmi.no/2025/03/10/forskere-slik-demper-du-kronisk-smerte/ 2025-03-10T10:35:15+00:00 https://www.lmi.no/2025/03/10/novo-nordisk-senker-listeprisen-pa-wegovy-i-usa/ 2025-03-10T10:36:12+00:00 https://www.lmi.no/2025/03/10/kreftforeningen-sterkt-beklagelig-om-partene-ikke-finner-en-raskere-losning/ 2025-03-10T10:37:55+00:00 https://www.lmi.no/2025/03/10/spreng-forsvarer-avslaget-pa-prisavtale-peker-tilbake-pa-msd/ 2025-03-10T10:38:50+00:00 https://www.lmi.no/2025/03/10/bevilger-nye-millioner-til-kommersialisering-av-forskning-atte-helseprosjekter-far-stotte/ 2025-03-10T10:39:47+00:00 https://www.lmi.no/2025/03/10/vil-ramme-norske-pasienter/ 2025-03-10T10:40:47+00:00 https://www.lmi.no/2025/03/10/slapphet-og-trotthet-er-ikke-nodvendigvis-en-tilstrekkelig-diagnose-for-a-bli-ufor/ 2025-03-10T10:41:55+00:00 https://www.lmi.no/2025/03/10/ventetiden-for-helsedata-til-forskning-har-gatt-opp-igjen/ 2025-03-10T10:42:42+00:00 https://www.lmi.no/2025/03/10/ous-forsker-kalte-kll-data-et-gjennombrudd-na-blir-det-nytt-ja-i-eu/ 2025-03-10T10:43:35+00:00 https://www.lmi.no/2025/03/10/dmp-har-brutt-egen-tidsfrist-i-vurdering-av-migrenemedisin-for-andre-gang/ 2025-03-10T10:44:21+00:00 https://www.lmi.no/2025/03/10/anbefaler-godkjenning-av-columvi-i-ny-behandling-for-aggressiv-blodkreft/ 2025-03-10T10:45:54+00:00 https://www.lmi.no/2025/03/10/helsedirektoratet-anbefaler-kortere-antibiotikakurer/ 2025-03-10T10:46:45+00:00 https://www.lmi.no/2025/03/10/fhi-fryktar-feil-informasjon-fra-amerikanske-forskarar/ 2025-03-10T10:47:27+00:00 https://www.lmi.no/2025/03/10/lmi-i-khrono-livsvitenskap-er-viktig-for-fremtiden/ 2025-03-10T11:30:41+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Skjermbilde-2025-03-10-122226-1.png https://www.lmi.no/wp-content/uploads/2025/03/Skjermbilde-2025-03-10-122226-1.png https://www.lmi.no/2025/03/12/lmi-i-altinget-5-ar-siden-pandemien-har-vi-ikke-glemt-noe/ 2025-03-12T09:47:48+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Skjermbilde-Altinget-5-ar-siden-pandemien.png https://www.lmi.no/wp-content/uploads/2025/03/Skjermbilde-Altinget-5-ar-siden-pandemien.png https://www.lmi.no/2025/03/12/covid-19-fem-ar-siden-norge-stengte-hva-har-vi-laert/ 2025-03-12T11:19:56+00:00 https://www.lmi.no/2025/03/12/vi-har-aldri-hatt-bedre-sjanse-til-a-bygge-helseberedskap-enn-na/ 2025-03-12T11:28:28+00:00 https://www.lmi.no/2025/03/12/har-startet-jakten-pa-en-kur-mot-den-utbredte-kvinnesykdommen/ 2025-03-12T11:29:25+00:00 https://www.lmi.no/2025/03/12/flere-far-autoimmune-sykdommer-i-nord-norge-forskerne-vet-ikke-hvorfor/ 2025-03-12T11:31:40+00:00 https://www.lmi.no/2025/03/12/legeforeningen-vi-kan-ikke-stole-pa-flaksen-neste-gang/ 2025-03-12T11:36:07+00:00 https://www.lmi.no/2025/03/12/roche-henter-novo-nordisk-topp-til-fedmesatsing/ 2025-03-12T11:38:39+00:00 https://www.lmi.no/2025/03/12/ni-av-ti-leger-har-mistet-tillit-til-toppledelsen-etter-at-et-livsfarlig-datasystem-ble-innfort/ 2025-03-12T11:39:54+00:00 https://www.lmi.no/2025/03/12/internasjonale-aktorer-dominerer-helsepatenter-i-norge/ 2025-03-12T11:41:42+00:00 https://www.lmi.no/2025/03/12/anbefaler-utfasing-av-rensefisk-innen-2029/ 2025-03-12T11:43:01+00:00 https://www.lmi.no/2025/03/12/pille-mot-forhatt-oppkast-virus-bedre-beskyttelse/ 2025-03-12T11:44:50+00:00 https://www.lmi.no/2025/03/12/lovforslag-om-legemiddelmangel-vil-investere-mer-i-produksjon-av-kritiske-legemidler-i-eu/ 2025-03-12T11:46:40+00:00 https://www.lmi.no/2025/03/12/seks-viktige-grep-i-kampen-mot-antibiotikaresistens/ 2025-03-12T11:49:43+00:00 https://www.lmi.no/2025/03/12/roche-satser-57-milliarder-pa-nytt-dansk-fedmelegemiddel/ 2025-03-12T11:51:38+00:00 https://www.lmi.no/2025/03/12/stensland-hvorfor-ma-300-kreftpasienter-vente-pa-livsviktig-behandling/ 2025-03-12T11:52:45+00:00 https://www.lmi.no/2025/03/12/kreftforeningen-sterkt-beklagelig-om-partene-ikke-finner-en-raskere-losning-2/ 2025-03-12T11:54:08+00:00 https://www.lmi.no/2025/03/12/fhis-nye-helsedatastrategi-data-ut-har-hoyeste-prioritet/ 2025-03-12T12:37:56+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Forside-FHIs-helsedatastrategi.png https://www.lmi.no/wp-content/uploads/2025/03/Forside-FHIs-helsedatastrategi.png https://www.lmi.no/wp-content/uploads/2025/03/Helsedata-strategi-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Helsedata-Tor-og-Maria-scaled.jpg https://www.lmi.no/2025/03/13/over-halvparten-strok-i-farmasi-uvanlig/ 2025-03-13T09:39:46+00:00 https://www.lmi.no/2025/03/13/debatt-innovasjonene-star-klare-hvorfor-rigges-det-ikke-bedre/ 2025-03-13T09:41:08+00:00 https://www.lmi.no/2025/03/13/seks-viktige-grep-i-kampen-mot-antibiotikaresistens-2/ 2025-03-13T09:43:39+00:00 https://www.lmi.no/2025/03/13/roche-satser-57-milliarder-pa-nytt-dansk-fedmelegemiddel-2/ 2025-03-13T09:44:38+00:00 https://www.lmi.no/2025/03/13/msd-investerer-milliarder-i-utvidelse-av-vaksineproduksjonen-i-usa/ 2025-03-13T09:45:41+00:00 https://www.lmi.no/2025/03/13/over-12-millioner-koronavaksiner-ble-satt-i-norge-i-lopet-av-fem-ar/ 2025-03-13T09:46:38+00:00 https://www.lmi.no/2025/03/13/lmi-kritiske-til-nytt-eu-direktiv/ 2025-03-13T09:47:41+00:00 https://www.lmi.no/2025/03/14/utlysning-to-ledige-plasser-i-lmis-innovasjonsutvalg/ 2025-03-14T10:55:57+00:00 https://www.lmi.no/wp-content/uploads/2022/03/utvalg-crop.png https://www.lmi.no/wp-content/uploads/2022/03/utvalg-crop.png https://www.lmi.no/2025/03/14/det-er-pasientene-vi-jobber-for/ 2025-03-14T11:38:54+00:00 https://www.lmi.no/2025/03/14/wegovy-er-na-pa-svenske-apotek-novo-nordisk-soker-om-refusjon-i-sverige/ 2025-03-14T11:39:57+00:00 https://www.lmi.no/2025/03/14/kommentar-feil-om-antibiotika/ 2025-03-14T11:41:06+00:00 https://www.lmi.no/2025/03/14/debatt-norge-bor-utvikle-og-produsere-vaksiner-usa-er-bare-en-av-grunnene-til-det/ 2025-03-14T11:42:04+00:00 https://www.lmi.no/2025/03/14/derfor-mener-de-at-vi-hadde-handtert-en-helsekrise-bedre-i-dag/ 2025-03-14T11:42:54+00:00 https://www.lmi.no/2025/03/14/eli-lillys-konsernsjef-far-lonnsokning-nadde-311-millioner-norske-kroner-i-2024/ 2025-03-14T11:44:12+00:00 https://www.lmi.no/2025/03/14/apotekforeningen-advarer-viktige-legemidler-kan-forsvinne-uten-endringer-i-serviceproduksjonsordningen/ 2025-03-14T11:45:09+00:00 https://www.lmi.no/2025/03/14/stromfeil-forte-til-milliardtap-for-novo-nordisk-vi-er-tvunget-til-a-bli-et-lite-nettselskap/ 2025-03-14T11:46:01+00:00 https://www.lmi.no/2025/03/14/store-legemiddelselskaper-har-okt-sikkerheten-etter-drapet-pa-toppsjefen-i-united-healthcare/ 2025-03-14T11:46:55+00:00 https://www.lmi.no/2025/03/11/frokostmote-om-helsedata-hvordan-kan-microdata-no-hjelpe/ 2025-03-17T13:04:00+00:00 https://www.lmi.no/wp-content/uploads/2024/11/Helsedata_ny-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/11/Helsedata_ny-scaled.jpeg https://www.lmi.no/2025/03/17/studie-norske-helseregistre-kan-erstatte-kontrollgrupper-i-kliniske-studier/ 2025-03-17T17:39:56+00:00 https://www.lmi.no/2025/03/17/debatt-forskningsfond/ 2025-03-17T17:47:04+00:00 https://www.lmi.no/2025/03/17/beslutningsforum-ville-ha-i-pose-og-sekk/ 2025-03-17T17:48:29+00:00 https://www.lmi.no/2025/03/17/forventer-resultater-pa-norsk-legemiddelkandidat-i-sommer/ 2025-03-17T17:49:18+00:00 https://www.lmi.no/2025/03/17/helt-uventet-oppdagelse-slik-kan-et-vanlig-legemiddel-hindre-spredning-av-kreft/ 2025-03-17T17:50:07+00:00 https://www.lmi.no/2025/03/17/kjerkol-mener-ap-ma-ta-eu-debatten-na/ 2025-03-17T17:51:14+00:00 https://www.lmi.no/2025/03/17/bergenbio-tar-med-meglerhus-i-jakten-pa-ny-strategi/ 2025-03-17T17:52:02+00:00 https://www.lmi.no/2025/03/17/astrazeneca-kjoper-celleterapiselskap/ 2025-03-17T17:52:50+00:00 https://www.lmi.no/2025/03/17/deltakelse-i-nytt-prosjekt-om-alternative-prisavtaler/ 2025-03-17T18:01:21+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/2025/03/17/nytt-styre-i-lmi-5/ 2025-03-18T08:32:46+00:00 https://www.lmi.no/wp-content/uploads/2025/03/IMG_7564-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/IMG_7564-scaled.jpg https://www.lmi.no/2025/03/18/debatt-konkurransen-om-industrifinansierte-kliniske-studier-blir-stadig-skarpere-slik-kan-vi-hevde-oss/ 2025-03-18T09:18:00+00:00 https://www.lmi.no/2025/03/18/kan-vaere-dodelig-dobling-i-antall-vaksineringer-mot-flattsykdommen/ 2025-03-18T09:18:54+00:00 https://www.lmi.no/2025/03/18/advarer-mot-uautoriserte-celleterapier/ 2025-03-18T09:19:48+00:00 https://www.lmi.no/2025/03/18/novo-nordisk-tilbake-i-britisk-industriorganisasjon-etter-linkedin-bommert/ 2025-03-18T09:20:51+00:00 https://www.lmi.no/2025/03/18/beslutningsforum-om-lymfom-ja-apenbart-viktig-a-innfore/ 2025-03-18T09:23:07+00:00 https://www.lmi.no/2025/03/18/dette-er-det-nye-styret-i-lmi/ 2025-03-18T09:24:55+00:00 https://www.lmi.no/2025/03/18/beslutningsforum-godkjenner-atte-nye-legemidler-for-sykehusbruk/ 2025-03-18T09:27:21+00:00 https://www.lmi.no/2025/03/18/norsk-alzheimer-forskning-far-90-millioner-fra-eu/ 2025-03-18T09:28:14+00:00 https://www.lmi.no/2025/03/18/kronikk-konkurransen-om-industrifinansierte-kliniske-studier-blir-stadig-skarpere-slik-kan-vi-hevde-oss/ 2025-03-19T08:26:02+00:00 https://www.lmi.no/wp-content/uploads/2025/03/skjermdump-2-dm-kronikk-mars-25.png https://www.lmi.no/wp-content/uploads/2025/03/skjermdump-2-dm-kronikk-mars-25.png https://www.lmi.no/2025/03/19/fellesnordiske-pakninger-pa-engelsk-godkjent/ 2025-03-19T13:56:37+00:00 https://www.lmi.no/wp-content/uploads/2017/07/apotekbytte.jpg https://www.lmi.no/wp-content/uploads/2017/07/apotekbytte.jpg https://www.lmi.no/2025/03/21/flattvirus-40-prosent-flere-tbe-vaksiner-solgt-i-fjor/ 2025-03-21T10:40:42+00:00 https://www.lmi.no/2025/03/21/sa-mye-bruker-sykehus-norge-pa-legemidler/ 2025-03-21T10:41:43+00:00 https://www.lmi.no/2025/03/21/forslag-om-kritiske-legemidler-ser-til-norsk-innkjopsmetodikk-positivt/ 2025-03-21T10:42:37+00:00 https://www.lmi.no/2025/03/21/to-legemidler-valgt-ut-til-nordisk-pilotordning/ 2025-03-21T10:43:28+00:00 https://www.lmi.no/2025/03/21/roche-og-genentech-apner-innovasjonssenter-ved-harvard-university/ 2025-03-21T10:44:21+00:00 https://www.lmi.no/2025/03/21/norge-sier-ja-sverige-sier-nei-hvorfor-ma-norske-pasienter-likevel-vente-pa-helvetesildvaksine/ 2025-03-21T10:45:24+00:00 https://www.lmi.no/2025/03/21/legemiddelselskaper-vil-skjerme-medisiner-fra-tollkrigen/ 2025-03-21T10:46:32+00:00 https://www.lmi.no/2025/03/21/astrazenecas-livmorkreftmedisin-utkonkurrerer-cellegift-i-studie/ 2025-03-21T10:47:29+00:00 https://www.lmi.no/2025/03/21/novartis-far-blaresept-avslag-etter-fire-ar-haper-denne-saken-horer-historien-til/ 2025-03-21T10:48:44+00:00 https://www.lmi.no/2025/03/21/forvalter-milliarder-av-helsekroner-svekker-innsyn-med-tungvint-system/ 2025-03-21T10:49:57+00:00 https://www.lmi.no/2025/03/21/helsedata-i-kliniske-studier-trenger-ikke-lenger-ta-10-12-ar-a-utvikle-et-legemiddel/ 2025-03-21T10:50:48+00:00 https://www.lmi.no/2025/03/21/migrene-fravaer-tredoblet-svein-olav-hadde-hodepine-26-dager-i-februar/ 2025-03-21T10:53:01+00:00 https://www.lmi.no/2025/03/21/kritiske-legemidler-positivt-at-eu-har-blitt-inspirert-av-norsk-innkjopsmetodikk/ 2025-03-21T10:54:01+00:00 https://www.lmi.no/2025/03/21/sykehusinnjop-betalte-200-000-kroner-for-syv-siders-analyse-som-bare-brukte-apne-kilder-star-til-forventet-kostnad/ 2025-03-21T10:55:37+00:00 https://www.lmi.no/2025/03/21/sykehusinnkjop-avslutter-ikke-samarbeidet-med-teva/ 2025-03-21T10:56:26+00:00 https://www.lmi.no/2025/03/21/na-far-svenske-pasienter-tilgang-til-velsipity-nesten-ett-ar-etter-nabolandene/ 2025-03-21T10:57:33+00:00 https://www.lmi.no/2025/03/24/johnson-johnson-vil-investere-over-611-milliarder-kroner-i-usa-de-neste-fire-arene/ 2025-03-24T09:48:52+00:00 https://www.lmi.no/2025/03/24/eksem-medisin-med-lovende-resultaterc/ 2025-03-24T09:50:46+00:00 https://www.lmi.no/2025/03/24/eli-lilly-har-lansert-mounjaro-i-verdens-mest-folkerike-land/ 2025-03-24T10:21:39+00:00 https://www.lmi.no/2025/03/24/ny-immunterapi-godkjenning-gir-hap-for-norske-lungekreftpasienter/ 2025-03-24T10:22:53+00:00 https://www.lmi.no/2025/03/24/danmark-sender-forslag-til-ny-europeisk-life-science-strategi/ 2025-03-24T10:24:34+00:00 https://www.lmi.no/2025/03/24/mistet-broren-til-meslinger-hor-pa-dem-som-vet-bedre/ 2025-03-24T10:25:47+00:00 https://www.lmi.no/2025/03/24/jarle-og-kona-ble-innlagt-med-flattsykdommen-tbe-apner-for-vaksineprogram/ 2025-03-24T10:26:55+00:00 https://www.lmi.no/2025/03/24/kronikk-norge-bor-fa-mer-igjen-for-helsesamarbeidet-med-eu/ 2025-03-24T10:28:08+00:00 https://www.lmi.no/2025/03/24/drar-du-utenlands-for-a-fikse-utseendet-kan-du-sette-norge-i-fare/ 2025-03-24T10:29:45+00:00 https://www.lmi.no/2025/03/24/tester-ny-medisin-mot-depresjon-lovende/ 2025-03-24T10:30:33+00:00 https://www.lmi.no/2025/03/24/helseministeren-sier-nei-til-a-evaluere-fast-track-na-far-kritikk-fra-kreftforeningen-og-hoyre/ 2025-03-24T10:31:49+00:00 https://www.lmi.no/2025/03/24/abbvie-saksoker-dansk-legemiddelselskap-i-usa/ 2025-03-24T10:32:37+00:00 https://www.lmi.no/2025/03/24/sjosetter-plattform-for-oppfolging-av-hjertepasienter-med-novartis-og-ahus/ 2025-03-24T10:33:23+00:00 https://www.lmi.no/2025/03/24/debatt-prioriteringsmeldingen-ma-handtere-usikkerhet-ikke-diskvalifisere/ 2025-03-24T13:21:30+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Skjermbilde-2025-03-24-140809.png https://www.lmi.no/wp-content/uploads/2025/03/Skjermbilde-2025-03-24-140809.png https://www.lmi.no/2025/03/24/lmi-om-systemmeldingen/ 2025-03-24T13:45:42+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Front-systemmeldingen-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/03/Front-systemmeldingen-2025.png https://www.lmi.no/2025/03/26/debatt-prioriteringsmeldingen-ma-handtere-usikkerhet-ikke-diskvalifisere-2/ 2025-03-26T09:16:58+00:00 https://www.lmi.no/2025/03/26/danmark-apner-for-alternative-avtaler-sikrer-pasienter-nye-legemidler-raskere/ 2025-03-26T09:17:58+00:00 https://www.lmi.no/2025/03/26/debatt-vaksinering-av-risikoutsatte-barn-prioriteres-ikke/ 2025-03-26T09:26:36+00:00 https://www.lmi.no/2025/03/26/farmaceutene-vi-ma-fa-flere-til-a-levere-ubrukte-legemidler-pa-apotek/ 2025-03-26T09:29:45+00:00 https://www.lmi.no/2025/03/26/ny-teknologi-skal-gi-bedre-oppfolging-av-hjertepasienter/ 2025-03-26T09:30:48+00:00 https://www.lmi.no/2025/03/26/bakterier-kjenner-ingen-landegrenser/ 2025-03-26T09:32:07+00:00 https://www.lmi.no/2025/03/26/voksenvaksinasjon-msd-kritiske-til-at-anbud-ble-lukket-for-horingsfrist/ 2025-03-26T09:33:11+00:00 https://www.lmi.no/2025/03/26/skal-kjempe-om-vaksineavtale-verdt-169-millioner-kroner/ 2025-03-26T09:34:07+00:00 https://www.lmi.no/2025/03/26/bristol-myers-squibb-far-ny-norden-direktor/ 2025-03-26T09:35:32+00:00 https://www.lmi.no/2025/03/26/novo-nordisk-inngar-milliardavtale-med-kinesisk-bioteknologiselskap/ 2025-03-26T09:36:27+00:00 https://www.lmi.no/2025/03/26/oncoinvent-gar-videre-med-fase-2-studie-etter-positiv-sikkerhetsgjennomgang/ 2025-03-26T09:37:21+00:00 https://www.lmi.no/2025/03/26/bayer-tapte-i-retten-ma-ut-med-over-to-milliarder-dollar-til-saksoker/ 2025-03-26T09:45:05+00:00 https://www.lmi.no/2025/03/26/thor-medical-trykker-pa-startknappen-for-investering-pa-200-millioner-kroner/ 2025-03-26T09:46:11+00:00 https://www.lmi.no/2025/03/26/stor-ettersporsel-etter-ferdigfylt-oyemedisin-kan-skape-forsinkelser-i-norge/ 2025-03-26T09:47:35+00:00 https://www.lmi.no/2025/03/26/novo-nordisk-er-ikke-lenger-europas-storste-borsnoterte-selskap/ 2025-03-26T09:48:31+00:00 https://www.lmi.no/2025/03/26/norsk-studie-pa-benmargskreft-far-plass-i-europeiske-retningslinjer-aldri-skjedd-for/ 2025-03-26T09:49:24+00:00 https://www.lmi.no/2025/03/26/astrazeneca-toppen-roser-kina-etter-miliardinvestering/ 2025-03-26T09:50:29+00:00 https://www.lmi.no/2025/03/27/ge-healthcare-star-for-halve-helseeksporten-i-norge-hva-skjer-hvis-de-flytter/ 2025-03-27T08:50:39+00:00 https://www.lmi.no/2025/03/27/parkinsons-kan-ramme-dobbelt-sa-mange-innen-2050-vi-ma-mote-denne-okningen-med-forskning/ 2025-03-27T08:51:27+00:00 https://www.lmi.no/2025/03/27/possibia-har-laget-google-for-kliniske-studier/ 2025-03-27T08:52:13+00:00 https://www.lmi.no/2025/03/27/msd-inngar-multi-milliardavtale-med-kinesisk-selskap/ 2025-03-27T08:52:59+00:00 https://www.lmi.no/2025/03/27/har-publisert-data-pa-bergenbio-kandidat/ 2025-03-27T08:53:45+00:00 https://www.lmi.no/2025/03/27/debatt-fra-ms-revolusjonen-til-alzheimer-en-ny-aera-for-behandling/ 2025-03-27T08:55:00+00:00 https://www.lmi.no/2025/03/27/trump-vil-stanse-okonomisk-stotte-til-vaksinealliansen-gavi/ 2025-03-27T08:55:48+00:00 https://www.lmi.no/2025/03/27/bayer-utfordrer-pfizers-monopol-pa-hjertemedisin/ 2025-03-27T08:56:39+00:00 https://www.lmi.no/2025/03/27/lmis-forventninger-til-prioriteringsmeldingen/ 2025-03-27T08:59:17+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/2025/03/28/toppledelsen-og-styret-trekker-seg-i-nykode/ 2025-03-28T09:24:58+00:00 https://www.lmi.no/2025/03/28/akutt-mangel-pa-medisin-mot-blodkreft-krever-hasteinnforing-av-nytt-legemiddel/ 2025-03-28T09:26:41+00:00 https://www.lmi.no/2025/03/28/bare-7-prosent-tror-regjeringen-vil-klare-ventetidsloftet/ 2025-03-28T09:27:44+00:00 https://www.lmi.no/2025/03/28/rapport-ett-nytt-legemiddel-kostet-i-snitt-23-milliarder-kroner-a-utvikle/ 2025-03-28T09:28:34+00:00 https://www.lmi.no/2025/03/28/lederflukten-i-nykode-visste-ingenting-da-jeg-vaknet-i-dag/ 2025-03-28T09:29:23+00:00 https://www.lmi.no/2025/03/28/senatet-bekrefter-marty-makary-som-ny-fda-kommissaer/ 2025-03-28T09:30:12+00:00 https://www.lmi.no/2025/03/28/svakt-om-helseindustri-i-industrimeldingen/ 2025-03-28T17:47:48+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Monica-og-industrimeldingen.png https://www.lmi.no/wp-content/uploads/2025/03/Industrimeldingen-forside.png https://www.lmi.no/wp-content/uploads/2023/01/Monica-Larsen--scaled.jpg https://www.lmi.no/2025/03/31/pakningsvedlegg-pa-papir-er-forhistorisk-2/ 2025-03-31T07:29:04+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Dino1_Landingsside.png https://www.lmi.no/wp-content/uploads/2025/03/Dino1_Landingsside.png https://www.lmi.no/2025/03/31/dette-sier-industrimeldingen-om-helsenaering-livsvitenskap-og-legemiddelindustri/ 2025-03-31T08:02:39+00:00 https://www.lmi.no/2025/03/31/chmp-anbefaler-ikke-godkjenning-av-eli-lillys-alzheimer-behandling/ 2025-03-31T08:03:29+00:00 https://www.lmi.no/2025/03/31/debatt-hvordan-skal-vi-prioritere-pasienter-med-sjeldne-tilstander/ 2025-03-31T08:04:57+00:00 https://www.lmi.no/2025/03/31/tepkinly-skal-metodevurderes-for-follikulaert-lymfom/ 2025-03-31T08:06:53+00:00 https://www.lmi.no/2025/03/31/nordby-lunde-h-om-norsk-helsenaering-vi-blir-slatt-ned-i-stovlene-av-danmark-og-sverige/ 2025-03-31T08:08:57+00:00 https://www.lmi.no/2025/03/31/novo-nordisk-soker-om-utvidet-bruk-av-glp-1-pille/ 2025-03-31T10:17:42+00:00 https://www.lmi.no/2025/03/31/ny-studie-pa-slankelegemiddel-reduserer-risiko-for-hjertehendelser/ 2025-03-31T10:20:00+00:00 https://www.lmi.no/2025/03/31/dropper-metodevurdering-av-kll-behandling-kan-bli-priskonkurranse/ 2025-03-31T10:25:12+00:00 https://www.lmi.no/2025/04/01/roser-tribune-therapeutics-for-selvtilliten-rollemodeller/ 2025-04-01T09:13:46+00:00 https://www.lmi.no/2025/04/01/advarer-mot-for-hoy-husleie-i-nytt-livsvitenskapsbygg/ 2025-04-01T09:15:37+00:00 https://www.lmi.no/2025/04/01/nho-topp-staten-bor-vera-i-front-med-a-setja-pengar-i-uavhengig-forskingsfond/ 2025-04-01T09:16:45+00:00 https://www.lmi.no/2025/04/01/skal-paklage-negativ-anbefaling-om-alzheimer-medisin/ 2025-04-01T09:17:40+00:00 https://www.lmi.no/2025/04/01/eli-lilly-far-avslag-i-europa-for-alzheimers-medisin-risiko-vurderes-som-for-hoy/ 2025-04-01T09:18:38+00:00 https://www.lmi.no/2025/04/01/sterk-okning-i-bruken-av-legemidler-for-vektnedgang-ogsa-blant-barn/ 2025-04-01T09:19:30+00:00 https://www.lmi.no/2025/04/01/ny-antibiotika-for-urinveisinfeksjon-godkjent-i-usa-for-forste-gang-pa-30-ar/ 2025-04-01T09:20:34+00:00 https://www.lmi.no/2025/04/01/novartis-legemidlet-pluvicto-far-utvidet-godkjenning-i-usa-tredobler-pasientgrunnlaget/ 2025-04-01T09:22:00+00:00 https://www.lmi.no/2025/04/01/norge-implementerer-nye-eu-regler-om-medisinske-metodevurderinger/ 2025-04-01T09:22:58+00:00 https://www.lmi.no/2025/04/02/sintef-forsker-har-stor-tro-pa-microdata-no/ 2025-04-02T05:26:24+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Microdata_SSB_Sintef_LMIcrop-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Microdata_SSB_Sintef_LMIcrop-scaled.jpg https://www.lmi.no/2025/04/02/disse-vaksinene-bor-voksne-ta-ifolge-ekspertene/ 2025-04-02T10:25:55+00:00 https://www.lmi.no/2025/04/02/millioner-dor-helt-unodvendig-av-tuberkulose-kan-det-bli-verre/ 2025-04-02T10:27:09+00:00 https://www.lmi.no/2025/04/02/jpmorgan-mener-den-europeiske-legemiddelsektoren-kan-handtere-trumps-tollsatser/ 2025-04-02T10:28:06+00:00 https://www.lmi.no/2025/04/02/anbefaler-immunterapi-som-injeksjon/ 2025-04-02T10:29:54+00:00 https://www.lmi.no/2025/04/02/bayer-har-fatt-to-blareseptavslag-pa-tre-ar-for-samme-legemiddel/ 2025-04-02T10:30:15+00:00 https://www.lmi.no/2025/04/02/novo-nordisk-gar-mot-sin-verste-aksjemaned-siden-2002/ 2025-04-02T10:31:00+00:00 https://www.lmi.no/2025/04/02/lovende-resultater-for-ungdom-med-alvorlig-haravfall-na-skal-beslutningsforum-ta-stilling-for-voksne/ 2025-04-02T10:32:05+00:00 https://www.lmi.no/2025/04/03/gar-fra-ultimovacs-til-nadeno/ 2025-04-03T07:50:35+00:00 https://www.lmi.no/2025/04/03/ny-prioriteringsmelding-vi-trenger-en-storre-prioriteringsdebatt/ 2025-04-03T07:51:37+00:00 https://www.lmi.no/2025/04/03/fullt-hus-pa-leverandorseminar-for-legemidler/ 2025-04-03T07:53:45+00:00 https://www.lmi.no/2025/04/03/dette-er-det-neste-norske-selskapet-som-skal-flytte-inn-hos-astrazeneca/ 2025-04-03T07:54:33+00:00 https://www.lmi.no/2025/04/03/lmi-reagerer-pa-medisinavgjorelse-dette-gar-ut-over-norges-omdomme/ 2025-04-03T07:57:02+00:00 https://www.lmi.no/2025/04/03/norsk-studie-dodelighet-etter-hjerteinfarkt-faller-men-en-gruppe-har-svaert-darlig-prognose/ 2025-04-03T08:07:28+00:00 https://www.lmi.no/2025/04/03/motstridende-beskjeder-skaper-toll-forvirring-hos-legemiddelindustrien/ 2025-04-03T08:08:26+00:00 https://www.lmi.no/2025/04/03/vil-ha-ja-kultur-i-helsevesenet-fa-bort-byrakratisk-idioti/ 2025-04-03T11:36:55+00:00 https://www.lmi.no/2025/04/04/novartis-trekker-ms-medisin-fra-norsk-anbud-deltar-ikke-pa-like-vilkar/ 2025-04-04T11:36:09+00:00 https://www.lmi.no/2025/04/04/trump-administrasjonen-retter-kritikk-mot-beslutningsforum-i-handelsrapport/ 2025-04-04T11:37:30+00:00 https://www.lmi.no/2025/04/04/norsk-studie-fant-vapen-mot-resistente-bakterier/ 2025-04-04T11:38:31+00:00 https://www.lmi.no/2025/04/04/har-innstilt-nytt-styre-i-thor-medical/ 2025-04-04T11:39:38+00:00 https://www.lmi.no/2025/04/04/gir-seg-ikke-i-kampen-for-livsvitenskapsstrategi-na-mobiliserer-hoyre-tungvekterne/ 2025-04-04T11:41:40+00:00 https://www.lmi.no/2025/04/04/jj-endrer-strategi-etter-head-to-head-studie-med-astrazeneca-medikament/ 2025-04-04T11:42:34+00:00 https://www.lmi.no/2025/04/02/hoyre-foreslar-nasjonal-livsvitenskapsstrategi-i-stortinget/ 2025-04-04T11:46:29+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Stortinget-dok-8-livsvitenskapsstrategi.png https://www.lmi.no/wp-content/uploads/2025/04/Stortinget-dok-8-livsvitenskapsstrategi.png https://www.lmi.no/2025/04/04/digitalt-medlemsmote-om-usa-toll/ 2025-04-04T11:51:42+00:00 https://www.lmi.no/wp-content/uploads/2024/10/medlemsmote-scaled.jpg https://www.lmi.no/2025/04/07/kronikk-mer-samarbeid-med-naeringslivet/ 2025-04-07T08:41:04+00:00 https://www.lmi.no/2025/04/07/norge-innforte-viktig-lymfekreft-medisin-for-danmark-og-sverige/ 2025-04-07T08:42:26+00:00 https://www.lmi.no/2025/04/07/slankemedisin-kobles-til-tydelig-bivirkning-%e2%81%a0-kan-oppleves-dramatisk/ 2025-04-07T08:43:15+00:00 https://www.lmi.no/2025/04/07/europeisk-godkjenning-i-det-uvisse-dette-mener-norske-fagfolk-om-alzheimer-medisinen/ 2025-04-07T08:44:13+00:00 https://www.lmi.no/2025/04/07/sykehusinnkjop-mange-nei-i-beslutningsforum-kunne-vaert-unngatt/ 2025-04-07T08:46:40+00:00 https://www.lmi.no/2025/04/04/alzheimers-og-parkinsons-sykdom-biomarkorer-og-innovasjoner-gir-hap/ 2025-04-07T08:50:50+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Panelet-Wien-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Salen-Wien-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Ambassadoren-Wien-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Panelet-Wien-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Arrangorene-Wien-scaled.jpg https://www.lmi.no/2025/04/08/stoff-som-skaper-betennelse-ser-ut-til-a-bidra-til-alzheimers-sykdom/ 2025-04-08T09:28:33+00:00 https://www.lmi.no/2025/04/08/ny-pneumokokk-vaksine-eu-godkjent-beskytter-mot-21-undertyper-av-bakterie/ 2025-04-08T09:29:29+00:00 https://www.lmi.no/2025/04/08/novo-nordisk-vil-tette-utslippsgapet-utfordrende-a-omsette-ambisjoner-til-konkrete-losninger/ 2025-04-08T09:30:31+00:00 https://www.lmi.no/2025/04/08/debatt-unntaksordningen-ma-gi-enkeltpasienter-behandling-raskere/ 2025-04-08T09:31:47+00:00 https://www.lmi.no/2025/04/08/faerre-milliardoppkjop-fra-legemiddelgigantene-i-forste-kvartal/ 2025-04-08T09:34:17+00:00 https://www.lmi.no/2025/04/08/legemiddelselskaper-kan-bli-rammet-av-trumps-masseoppsigelser/ 2025-04-08T09:35:04+00:00 https://www.lmi.no/2025/04/08/tidligere-bayer-norge-sjef-jan-borge-jakobsen-blir-sjef-for-thorium-norway/ 2025-04-08T09:36:02+00:00 https://www.lmi.no/2025/04/08/heder-til-forskere-innen-hjerte-og-demens-pris-til-sigrun-halvorsen-og-jens-pahnke/ 2025-04-08T09:37:10+00:00 https://www.lmi.no/2025/04/07/utvider-salen-for-helseokonomisk-fagdag/ 2025-04-08T09:38:34+00:00 https://www.lmi.no/wp-content/uploads/2025/01/HelseokDIG-2025.jpg https://www.lmi.no/2025/04/08/lmi-i-healthtalk-krever-bedre-veiledning-fra-sykehusinnkjop/ 2025-04-08T11:22:51+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Barb-i-HT-om-SHI.png https://www.lmi.no/wp-content/uploads/2025/04/Barb-i-HT-om-SHI.png https://www.lmi.no/2025/04/09/medlemsmotet-om-toll-i-opptak/ 2025-04-09T09:54:42+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Skjermbilde-2025-04-09-115229.png https://www.lmi.no/2025/04/09/varsler-ny-stor-toll/ 2025-04-09T10:01:30+00:00 https://www.lmi.no/2025/04/09/avbryter-utvikling-av-norskutviklet-legemiddelkandidat/ 2025-04-09T10:02:21+00:00 https://www.lmi.no/2025/04/09/nytt-pasientforlop-skal-sikre-raskere-hjelp-til-smertepasienter/ 2025-04-09T10:03:18+00:00 https://www.lmi.no/2025/04/09/novo-nordisk-investerer-12-milliarder-kroner-i-brasil/ 2025-04-09T10:04:07+00:00 https://www.lmi.no/2025/04/09/debatt-hpv-vaksinen-er-fortsatt-en-gullvaksine/ 2025-04-09T10:05:14+00:00 https://www.lmi.no/2025/04/09/ahus-lykkes-med-forskningssatsing-8-av-10-leger-deltar-i-kliniske-studier/ 2025-04-09T10:06:11+00:00 https://www.lmi.no/2025/04/09/legemiddelindustrien-skal-bidra-til-telemarks-naeringsvekst/ 2025-04-10T06:26:27+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Front-Legemiddelbedriftsnettverket-i-Grenland-og-fylkesordforer.jpg https://www.lmi.no/wp-content/uploads/2025/04/Legemiddelbedriftsnettverket-i-Grenland-og-fylkesordforer.jpg https://www.lmi.no/2025/04/10/tidligere-pfizer-topp-erik-hjelvin-blir-partner-i-first-house/ 2025-04-10T07:40:30+00:00 https://www.lmi.no/2025/04/10/nye-funn-om-menssmerter-og-endometriose-%e2%81%a0-ma-fa-bedre-hjelp/ 2025-04-10T07:43:22+00:00 https://www.lmi.no/2025/04/10/trump-varsler-hoye-tollsatser-pa-importerte-legemidler-skaper-enorm-turbulens/ 2025-04-10T07:44:21+00:00 https://www.lmi.no/2025/04/10/tar-kampen-mot-barnedemens-til-stortinget-det-er-ikke-alle-som-lytter-til-barn/ 2025-04-10T07:45:38+00:00 https://www.lmi.no/2025/04/10/ms-anbudet-tysabri-gjor-comeback-velges-foran-kopi-medisinen-tyruko/ 2025-04-10T07:46:53+00:00 https://www.lmi.no/2025/04/10/godkjenner-rinvoq-for-behandling-av-kjempecellearteritt/ 2025-04-10T07:47:48+00:00 https://www.lmi.no/2025/04/10/kreftforeningen-etablerer-ekspertgruppe-for-straleterapiforskning-har-hengt-litt-etter/ 2025-04-10T07:48:39+00:00 https://www.lmi.no/2025/04/10/novo-nordisk-brukte-404-millioner-dollar-pa-amerikansk-tv-reklame-for-wegovy-i-mars/ 2025-04-10T07:49:28+00:00 https://www.lmi.no/2025/04/10/lmi-om-prioriteringsmeldingen-en-falitterklaering-fra-regjeringen/ 2025-04-10T10:01:14+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-alvorlig-5967-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-alvorlig-5967-scaled.jpg https://www.lmi.no/2025/04/10/lmi-prioriteringsmeldingen-er-en-falitterklaering/ 2025-04-10T10:22:40+00:00 https://www.lmi.no/2025/04/10/vestre-na-kan-pasienter-fa-ja-etter-nei/ 2025-04-10T10:29:50+00:00 https://www.lmi.no/2025/04/10/lmi-kaller-prioriteringsmeldingen-en-falitterklaering-fra-regjeringen/ 2025-04-10T11:18:59+00:00 https://www.lmi.no/2025/04/10/gode-vaksinenyheter-i-prioriteringsmeldingen/ 2025-04-10T12:32:41+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Hausken-og-Rondan.png https://www.lmi.no/wp-content/uploads/2024/02/Line-Storesund-Rondan-2023.jpg https://www.lmi.no/wp-content/uploads/2023/01/anne-margrethe-crop-2-scaled-e1748933566845.jpg https://www.lmi.no/2025/04/11/tollbekymringer-for-norsk-legemiddelbransje/ 2025-04-11T09:59:21+00:00 https://www.lmi.no/2025/04/11/vil-utlyse-anbud-pa-utredning-av-alternativkostnaden-for-helse-og-omsorgstjenester/ 2025-04-11T10:01:41+00:00 https://www.lmi.no/2025/04/11/mener-prioriteringsmeldingen-er-en-fallitterklaering-og-onsker-endring-av-hele-beslutningssystemet/ 2025-04-11T10:02:32+00:00 https://www.lmi.no/2025/04/11/lmi-kaller-prioriteringsmeldingen-en-falitterklaering-fra-regjeringen-2/ 2025-04-11T10:03:22+00:00 https://www.lmi.no/2025/04/11/prioriteringsmeldingen-brukerorganisasjoner-og-to-klinikere-skal-fa-talerett-i-beslutningsforum/ 2025-04-11T10:04:15+00:00 https://www.lmi.no/2025/04/11/foreslar-at-dmp-skal-utrede-forslag-til-foringer-for-a-handtere-usikkerhet/ 2025-04-11T10:05:46+00:00 https://www.lmi.no/2025/04/11/vi-forventer-nye-tilnaerminger-som-ikke-bare-lapper-pa-beslutningssystemet/ 2025-04-11T10:06:34+00:00 https://www.lmi.no/2025/04/11/ny-banebrytende-behandling-anne-karen-ble-kreftfri/ 2025-04-11T10:09:13+00:00 https://www.lmi.no/2025/04/11/ny-unntaksordning-slaktes-av-jusprofessor-legeforeningen-og-kreftforeningen-er-skeptiske/ 2025-04-11T10:10:10+00:00 https://www.lmi.no/2025/04/11/to-medtek-selskaper-far-millionstotte-fra-forskningsradet/ 2025-04-11T10:11:05+00:00 https://www.lmi.no/2025/04/11/stoltenberg-slar-alarm-%e2%81%a0-det-er-viktigere-enn-oljen/ 2025-04-11T10:11:49+00:00 https://www.lmi.no/2025/04/11/hoyre-og-ap-vil-gjore-norge-til-ledestjerne-for-helsenaering-men-er-de-enige-om-veien-dit/ 2025-04-11T10:46:58+00:00 https://www.lmi.no/2025/04/23/svensk-biotekselskap-til-vaers-etter-milliardbud-oljefondet-med-betydelig-eierandel/ 2025-04-23T09:31:52+00:00 https://www.lmi.no/2025/04/23/kreftbehandling-fra-astrazeneca-viser-lovende-studieresultater/ 2025-04-23T09:35:14+00:00 https://www.lmi.no/2025/04/23/zelluna-nar-milepael-med-ny-avtale-klar-for-kliniske-studier-i-ar/ 2025-04-23T09:36:24+00:00 https://www.lmi.no/2025/04/23/novo-nordisk-raser-pa-borsen-etter-slankepillenyhet-fra-usa/ 2025-04-23T09:41:14+00:00 https://www.lmi.no/2025/04/23/ny-studie-trodelvy-i-kombinasjon-med-keytruda-bremser-svulstvekst-i-aggressiv-brystkreft/ 2025-04-23T09:41:59+00:00 https://www.lmi.no/2025/04/23/roche-vil-investere-over-500-milliarder-kroner-i-usa/ 2025-04-23T09:42:50+00:00 https://www.lmi.no/2025/04/23/styrelederen-i-lytix-biopharma-trekker-seg/ 2025-04-23T09:43:38+00:00 https://www.lmi.no/2025/04/23/100-200-benmargskreft-pasienter-kan-vaere-aktuelle-for-blenrep-gjennom-compassionate-use/ 2025-04-23T09:45:25+00:00 https://www.lmi.no/2025/01/10/meld-deg-pa-helseokonomisk-fagdag-2025/ 2025-04-23T11:55:26+00:00 https://www.lmi.no/wp-content/uploads/2025/01/HelseokDIG-2025.jpg https://www.lmi.no/wp-content/uploads/2025/01/HOLDING-Helseok-2025.png https://www.lmi.no/2025/03/24/forelopig-program-for-helseokonomisk-fagdag/ 2025-04-23T11:57:01+00:00 https://www.lmi.no/wp-content/uploads/2025/01/HelseokDIG-2025.jpg https://www.lmi.no/wp-content/uploads/2025/01/HelseokDIG-2025.jpg https://www.lmi.no/2025/04/23/fortsatt-skuffet-over-prioriteringsmeldingen/ 2025-04-24T08:22:50+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Leif-Rune-pa-DM-Arena-Prioriteringsmeldingen-2025.png https://www.lmi.no/wp-content/uploads/2025/04/Leif-Rune-pa-DM-Arena-Prioriteringsmeldingen-2025.png https://www.lmi.no/2025/04/24/lmi-pa-horing-i-stortinget-2/ 2025-04-24T09:27:07+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Leif-Rune-Skymoen-i-Stortinget-front-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/04/240425-Leif-Rune-Skymoen-i-Stortinget.png https://www.lmi.no/2025/04/24/medisinene-som-odelegger-nattesovnen/ 2025-04-24T09:41:26+00:00 https://www.lmi.no/2025/04/24/okning-i-bruk-av-hoye-doser-opioider-pa-resept/ 2025-04-24T09:41:41+00:00 https://www.lmi.no/2025/04/24/legemiddelindustri-topper-oppfordrer-eu-til-a-matche-amerikanske-priser/ 2025-04-24T09:42:27+00:00 https://www.lmi.no/2025/04/24/beslutningsforum-skal-vurdere-24-saker-igjen-star-ms-medisinen-okrelizumab-pa-agendaen/ 2025-04-24T09:43:15+00:00 https://www.lmi.no/2025/04/24/task-force-pa-priomeldingen/ 2025-04-24T12:07:18+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-alvorlig-5967-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/Skymoen.jpg https://www.lmi.no/2025/04/25/europeiske-legemiddelselskaper-krever-hoyere-medisinpriser-i-europa-etter-trusler-om-amerikanske-tollbarrierer/ 2025-04-25T11:30:08+00:00 https://www.lmi.no/2025/04/25/bekeng-mener-beslutningsforum-bruker-unodvendig-lang-tid-pa-saker-med-klart-utfall/ 2025-04-25T11:34:38+00:00 https://www.lmi.no/2025/04/25/legepresidenten-forvirret-over-ny-prioriteringsmelding-vi-trenger-mer-ghb/ 2025-04-25T11:35:50+00:00 https://www.lmi.no/2025/04/25/regjeringen-foreslar-at-bemanning-skal-telle-mer-i-prioriteringene-spent-pa-regnestykket/ 2025-04-25T11:37:18+00:00 https://www.lmi.no/2025/04/25/novo-nordisk-far-kopi-seier-i-usa/ 2025-04-25T11:39:02+00:00 https://www.lmi.no/2025/04/25/hoy-placeboeffekt-spoker-fremdeles-for-arctic-bioscience-studie/ 2025-04-25T11:40:12+00:00 https://www.lmi.no/2025/04/25/fosser-frem-ingen-kjopte-mer-norsk-laks-enn-kina/ 2025-04-25T11:42:35+00:00 https://www.lmi.no/2025/04/25/hod-om-ny-prioriteringsmelding-ryggdekning-for-prioritering-i-hele-helsetjenesten/ 2025-04-25T11:42:56+00:00 https://www.lmi.no/2025/04/28/dette-skjer-i-uke-18-frp-landsmote-og-kontrollsak-om-korona/ 2025-04-28T09:21:56+00:00 https://www.lmi.no/2025/04/28/hjerneforsker-advarer-mot-ukritisk-bruk-av-smertestillende-opioider/ 2025-04-28T09:22:43+00:00 https://www.lmi.no/2025/04/28/dmp-bruker-82-dager-pa-a-finne-eksperter-til-metodevurderinger-vet-ikke-hvorfor/ 2025-04-28T09:23:44+00:00 https://www.lmi.no/2025/04/28/mener-nye-dyre-legemidler-kommer-med-for-svake-data-gjor-det-vanskeligere-a-vurdere/ 2025-04-28T09:25:16+00:00 https://www.lmi.no/2025/04/28/uio-forsker-vil-ha-okt-bruk-av-norske-helsedata/ 2025-04-28T09:26:11+00:00 https://www.lmi.no/2025/04/28/forskere-vil-redde-39-millioner-liv-nytt-vapen-skal-drepe-superbakterier/ 2025-04-28T09:27:03+00:00 https://www.lmi.no/2025/04/28/debatt-forebygging-reduserer-ikke-trykket-pa-helsetjenestene/ 2025-04-28T09:28:14+00:00 https://www.lmi.no/2025/04/28/syv-nye-og-ni-biotilsvarende-legemidler-anbefalt-innfort-i-europa/ 2025-04-28T09:28:55+00:00 https://www.lmi.no/2025/04/28/rekordstort-mote-i-beslutningsforum-disse-25-sakene-skal-opp-til-behandling/ 2025-04-28T09:29:40+00:00 https://www.lmi.no/2025/04/28/prioriteringsmeldingen-kan-ikke-se-ut-som-en-gulost-med-fullt-av-hull-i/ 2025-04-28T11:16:59+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Helseokonomisk-fagdag-25-politikere-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Helseokonomisk-fagdag-25-politikere-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Helseokonomisk-fagdag-25-oversiktsbilde-scaled.jpg https://www.lmi.no/2025/04/29/sanofi-med-sterke-kvartalsinntekter-stor-ettersporsel-etter-blockbuster/ 2025-04-29T09:04:13+00:00 https://www.lmi.no/2025/04/29/ja-til-nye-lungekreftbehandlinger-immunterapi-gir-hap-om-lengre-overlevelse/ 2025-04-29T09:05:07+00:00 https://www.lmi.no/2025/04/29/nevrolog-om-dobbelt-ms-ja-i-beslutningsforum-etter-syv-ar-et-alternativ-for-noen-fa/ 2025-04-29T09:05:52+00:00 https://www.lmi.no/2025/04/29/europeiske-eksperter-kritiserer-eu-godkjenning-av-alzheimer-medisin/ 2025-04-29T09:06:50+00:00 https://www.lmi.no/2025/04/29/beslutningsforum-sier-ja-til-behandling-av-ms-lungekreft-og-blodkreft-men-nei-til-medisin-mot-alvorlig-haravfall/ 2025-04-29T09:07:44+00:00 https://www.lmi.no/2025/04/29/oncoinvent-med-nye-radspherin-data/ 2025-04-29T09:08:30+00:00 https://www.lmi.no/2025/04/29/eli-lilly-ber-ema-revurdere-alzheimer-behandling/ 2025-04-29T09:09:12+00:00 https://www.lmi.no/2025/04/29/egen-task-force-i-lmi-for-prioriteringsmeldingen/ 2025-04-29T10:22:20+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Prioriteringsmeldingen_2025.png https://www.lmi.no/wp-content/uploads/2025/04/Prioriteringsmeldingen_2025.png https://www.lmi.no/2025/04/29/frokostseminar-om-helsedata-data-fra-primaerhelsetjenesten/ 2025-04-29T10:43:03+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Legekontor-helsedata-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/04/Legekontor-helsedata-Adobe-Stock-scaled.jpeg https://www.lmi.no/2025/05/01/kronisk-syke-pasientgrupper-kan-fa-medisiner-levert-hjem/ 2025-05-01T10:07:58+00:00 https://www.lmi.no/2025/05/01/endelig-ja-til-fintepla-men-epilepsiforbundet-er-kritisk-til-lang-saksbehandling/ 2025-05-01T10:08:44+00:00 https://www.lmi.no/2025/05/01/forsker-pa-ms-medisinen-som-ble-innfort-veldig-gledelig-beslutning/ 2025-05-01T10:09:42+00:00 https://www.lmi.no/2025/05/01/dette-er-lytix-nye-styre/ 2025-05-01T10:11:24+00:00 https://www.lmi.no/2025/05/01/astrazenecas-toppsjef-advarer-mot-amerikansk-toll-pa-medisiner/ 2025-05-01T10:12:19+00:00 https://www.lmi.no/2025/05/01/astrazeneca-kan-fa-multimillion-bot-i-kina/ 2025-05-01T10:12:34+00:00 https://www.lmi.no/2025/05/01/beredskapsboom-i-norge/ 2025-05-01T10:13:18+00:00 https://www.lmi.no/2025/05/01/bergenbio-reduserte-kontantforbruket-kraftig/ 2025-05-01T10:13:58+00:00 https://www.lmi.no/2025/05/01/chicken-game-i-legemiddelforhandlingene-staten-blunker-sist/ 2025-05-01T10:14:56+00:00 https://www.lmi.no/2025/05/01/merck-vil-produsere-i-usa-for-forste-gang/ 2025-05-01T10:15:41+00:00 https://www.lmi.no/2025/05/02/haper-noen-vil-kjope-norsk-legemiddel-og-utvikle-det-videre-mulig-forste-og-annenlinjebehandling-for-leukemi/ 2025-05-02T10:20:56+00:00 https://www.lmi.no/2025/05/02/trumps-tolltrusler-kan-ramme-pasienter-og-investeringer-i-industrien/ 2025-05-02T10:21:47+00:00 https://www.lmi.no/2025/05/02/migrene-seier-for-pfizer-klage-forte-frem-etter-to-og-et-halvt-ar/ 2025-05-02T10:22:31+00:00 https://www.lmi.no/2025/05/02/medlemsmote-om-arets-wait-rapport-2/ 2025-05-02T11:02:38+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/2025/05/02/nye-bransjeregler-publisert/ 2025-05-02T11:51:55+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-02-134814-e1746186697985.png https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-02-134814-e1746186697985.png https://www.lmi.no/2025/05/05/ema-styret-vil-forlenge-leder-mandat/ 2025-05-05T10:41:45+00:00 https://www.lmi.no/2025/05/05/novo-nordisk-avtale-vekker-bekymring-hos-eli-lillys-investorer/ 2025-05-05T10:43:07+00:00 https://www.lmi.no/2025/05/05/norsk-studie-med-mulig-vaksine-gjennombrudd-%e2%81%a0-nesten-for-godt-til-a-vaere-sant/ 2025-05-05T10:43:55+00:00 https://www.lmi.no/2025/05/05/innforer-kreftmedisin-etter-ni-ars-ventetid-men-omstridt-anbudspraksis-fortsetter/ 2025-05-05T10:44:46+00:00 https://www.lmi.no/2025/05/06/to-nye-medlemmer-i-lmi/ 2025-05-06T07:28:38+00:00 https://www.lmi.no/wp-content/uploads/2025/05/To-nye-medlemmer-kopi-1.jpg https://www.lmi.no/wp-content/uploads/2025/05/To-nye-medlemmer-kopi-1.jpg https://www.lmi.no/2025/05/06/dra-forum-generalforsamling-og-medlemsmote/ 2025-05-06T07:58:37+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Antibtioka-apotek-legemidler-Adobe-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/11/Antibtioka-apotek-legemidler-Adobe-scaled.jpeg https://www.lmi.no/2025/05/06/farmasoyter-vil-sette-vaksiner-uten-godkjenning-fra-lege-vi-er-ikke-selgere/ 2025-05-06T08:52:05+00:00 https://www.lmi.no/2025/05/06/kunnskapsbasert-og-kvalitetsvurdert-er-mer-enn-en-professors-erfaringskompetanse/ 2025-05-06T08:52:56+00:00 https://www.lmi.no/2025/05/06/eli-lilly-direktor-mener-fremtidens-fedmebehandling-er-i-pilleform/ 2025-05-06T08:53:44+00:00 https://www.lmi.no/2025/05/06/sykehusinnkjop-topp-nicolai-maric-bjornaes-gar-til-ny-eu-stilling-flytter-til-brussel/ 2025-05-06T08:54:40+00:00 https://www.lmi.no/2025/05/06/fda-godkjenner-soknad-om-godkjenning-av-wegovy-i-oral-form/ 2025-05-06T08:55:25+00:00 https://www.lmi.no/2025/05/06/amgen-overgar-forventningene-fedmekandidat-naermer-seg-markedet/ 2025-05-06T08:56:07+00:00 https://www.lmi.no/2025/05/06/ema-anbefaler-16-nye-legemidler-for-godkjenning-i-eu/ 2025-05-06T08:56:53+00:00 https://www.lmi.no/2025/05/06/nevrolog-hyller-ny-migrenemedisin-men-advarer-mot-a-droppe-eldre-behandling/ 2025-05-06T08:57:38+00:00 https://www.lmi.no/2025/05/06/lmi-i-horing-om-prioriteringsmeldingen-usikkerhet-ma-ikke-bli-en-brems-for-ny-behandling/ 2025-05-06T11:38:30+00:00 https://www.lmi.no/wp-content/uploads/2025/05/LR-horing-prioriteringsmelding.png https://www.lmi.no/wp-content/uploads/2025/05/LR-horing-prioriteringsmelding.png https://www.lmi.no/2025/05/07/wait-fortsatt-lang-ventetid-og-lav-tilgjengelighet/ 2025-05-07T06:52:12+00:00 https://www.lmi.no/wp-content/uploads/2024/06/WAIT-BILDE-DIG-Nyhetssak-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/WAIT-BILDE-DIG-Nyhetssak-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Bilde1.png https://www.lmi.no/wp-content/uploads/2025/05/Bilde2.png https://www.lmi.no/2025/05/07/wait-rapporten-norske-pasienter-venter-524-dager-pa-tilgang-til-nye-medier/ 2025-05-07T07:23:03+00:00 https://www.lmi.no/2025/05/07/trump-vil-hente-legemiddelproduksjon-hjem-til-usa/ 2025-05-07T07:24:36+00:00 https://www.lmi.no/2025/05/07/sjelden-sykdom-og-kostbar-behandling-det-finnes-losninger-man-bor-kunne-finne-en-middelvei/ 2025-05-07T07:25:25+00:00 https://www.lmi.no/2025/05/07/positive-resultater-for-astma-behandling/ 2025-05-07T07:26:11+00:00 https://www.lmi.no/2025/05/07/mener-nye-tiltak-reduserer-behandlingstiden-for-innforing-av-nye-legemidler/ 2025-05-07T07:26:57+00:00 https://www.lmi.no/2025/05/07/kritiserer-ventetiden-for-tilgang-til-nye-behandlinger-i-norge/ 2025-05-07T07:28:28+00:00 https://www.lmi.no/2025/05/07/fhi-med-nye-tall-stadig-flere-blir-smittet-av-resistente-bakterier/ 2025-05-07T07:33:29+00:00 https://www.lmi.no/2025/05/07/novo-nordisk-fedmemiddel-skuffer-med-salget-til-tross-for-massiv-vekst/ 2025-05-07T07:34:28+00:00 https://www.lmi.no/2025/05/07/spetalen-selger-seg-ned-i-vistin-pharma/ 2025-05-07T07:35:00+00:00 https://www.lmi.no/2025/05/07/siste-frist-for-lov-og-bransjekurset/ 2025-05-07T10:27:32+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Deltagerne-Lov-og-bransje.jpeg https://www.lmi.no/wp-content/uploads/2019/08/Deltagerne-Lov-og-bransje.jpeg https://www.lmi.no/2025/05/07/partnerskapet-for-sjeldne-sykdommer-inviterte-til-rundebordsmote/ 2025-05-07T10:58:41+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Rundebordsmote_partnerskapet_salen-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Partnerskapet-for-sjeldne-sykdommer_mai-2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Rundebordsmote_partnerskapet_salen-1-scaled.jpg https://www.lmi.no/2025/05/08/offentliggjoringen-av-verdioverforinger-naermer-seg/ 2025-05-08T08:51:25+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Ramona-Melanie-Eichenberger-5639-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Ramona-Melanie-Eichenberger-5639-scaled.jpg https://www.lmi.no/2025/05/08/to-rapporter-om-ventetider-to-virkeligheter/ 2025-05-08T09:01:58+00:00 https://www.lmi.no/2025/05/08/uenige-om-behandlingstiden-for-nye-medisiner/ 2025-05-08T09:02:49+00:00 https://www.lmi.no/2025/05/08/wait-rapporten-norske-pasienter-venter-524-dager-pa-tilgang-til-nye-medisiner/ 2025-05-08T09:07:58+00:00 https://www.lmi.no/2025/05/08/exact-therapeutics-sikrer-patent-i-japan-styrker-kommersiell-posisjon-i-asia/ 2025-05-08T09:08:50+00:00 https://www.lmi.no/2025/05/08/dmp-sier-konstruktiv-dialog-var-avgjorende-for-at-migrene-legemiddel-fikk-gront-lys/ 2025-05-08T09:09:37+00:00 https://www.lmi.no/2025/05/08/alle-apotek-pa-ny-felles-it-plattform-storste-digitaliseringsloft-pa-20-ar/ 2025-05-08T09:13:52+00:00 https://www.lmi.no/2025/05/08/odd-erik-johansen-far-global-lederstilling-ved-hovedkontoret-til-roche-i-sveits/ 2025-05-08T09:14:38+00:00 https://www.lmi.no/2025/05/08/apen-horing-om-prioriteringsmeldingen-dmp-med-uttalelse-som-beskrives-som-sensasjonell/ 2025-05-08T09:15:37+00:00 https://www.lmi.no/2025/05/08/dmp-og-nye-metoder-nye-tiltak-kutter-tid-til-saksbehandling-industrien-trekker-ut-tiden/ 2025-05-08T09:51:46+00:00 https://www.lmi.no/2025/05/08/ge-healthcare-trukket-frem-pa-norsk-industris-arskonferanse/ 2025-05-08T10:44:42+00:00 https://www.lmi.no/wp-content/uploads/2025/05/54503287143_03fe2ae284_k.jpg https://www.lmi.no/wp-content/uploads/2025/05/54502157972_9718cc18dd_k.jpg https://www.lmi.no/2025/05/09/fotballtroyefredag-i-lmi/ 2025-05-09T11:12:36+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Lagbilde-fotballtroyefredag.jpg https://www.lmi.no/wp-content/uploads/2025/05/Lagbilde-fotballtroyefredag.jpg https://www.lmi.no/wp-content/uploads/2025/05/Fotballkort-bronsesponsor-scaled.jpg https://www.lmi.no/2025/05/09/dmp-onsker-storre-handlingsrom-til-a-prioritere-ressurser-til-metodevurderinger/ 2025-05-09T11:19:31+00:00 https://www.lmi.no/2025/05/09/pasientorganisasjoner-savner-samhandling-og-grep-pa-sjeldenfeltet-i-prioriteringsmeldingen/ 2025-05-09T11:20:52+00:00 https://www.lmi.no/2025/05/09/mener-norske-pasienter-ma-vente-for-lenge-pa-ny-medisin-forferdet/ 2025-05-09T11:21:38+00:00 https://www.lmi.no/2025/05/09/vaksiner-bor-nevnes-i-dsbs-liste-over-egenberedskap/ 2025-05-09T11:48:47+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Monica-og-Anne-Margrethe2.png https://www.lmi.no/wp-content/uploads/2023/01/Monica-Larsen--scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Anne-Margrethe-Hausken-Nordberg-6025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Nasjonal-sikkerhetsstrategi-2_forside.png https://www.lmi.no/wp-content/uploads/2025/02/IMG_4785.jpg https://www.lmi.no/2025/05/09/sissel-lonning-andresen-pa-plass-hos-nomvec/ 2025-05-09T12:23:57+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Sissel-Lonning-Andresen_Nomvec.jpg https://www.lmi.no/wp-content/uploads/2025/05/Sissel-Lonning-Andresen_Nomvec.jpg https://www.lmi.no/2025/05/12/mangel-pa-allergimedisin-over-hele-landet/ 2025-05-12T09:03:21+00:00 https://www.lmi.no/2025/05/12/trump-krever-at-usa-skal-fa-lavest-pris-pa-medisiner/ 2025-05-12T09:04:53+00:00 https://www.lmi.no/2025/05/12/flere-mindre-legemiddelbedrifter-far-markedsforings-ja-i-eu/ 2025-05-12T09:06:46+00:00 https://www.lmi.no/2025/05/12/knappest-mulig-margin-da-ny-alzheimer-medisin-ble-godkjent-i-eu-det-har-vaert-en-uvanlig-sak/ 2025-05-12T09:10:22+00:00 https://www.lmi.no/2025/05/12/brukinsa-innfort-som-forstelinjebehandling-for-kll-pasienter-i-norge/ 2025-05-12T09:11:21+00:00 https://www.lmi.no/2025/05/12/svs-marian-hussein-vil-erstatte-beslutningsforum-og-stanse-veksten-i-privat-helseforsikring/ 2025-05-12T09:12:10+00:00 https://www.lmi.no/2025/05/12/debatt-et-nasjonalt-rad-for-prioritering-ma-svare-direkte-til-helseministeren/ 2025-05-12T09:13:29+00:00 https://www.lmi.no/2025/05/12/trump-med-oppgjor-det-er-pinlig/ 2025-05-12T09:14:47+00:00 https://www.lmi.no/2019/06/25/maler-og-brosjyrer/ 2025-05-12T10:06:55+00:00 https://www.lmi.no/2025/05/12/dmp-ber-om-innspill-pa-forutsigbare-prosesser-pa-metodevurderinger/ 2025-05-12T10:18:38+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/2025/05/14/no-har-ventetida-auka-det-har-ikkje-pasientane-rad-til/ 2025-05-14T08:22:13+00:00 https://www.lmi.no/2025/05/14/legemiddelaksjer-stiger-etter-at-trumps-plan-er-bedre-enn-fryktet/ 2025-05-14T08:23:24+00:00 https://www.lmi.no/2025/05/14/trump-vil-ha-59-prosent-nedgang-i-legemiddelprisene/ 2025-05-14T08:24:32+00:00 https://www.lmi.no/2025/05/14/eli-lillys-mounjaro-slar-wegovy-i-direkte-sammenligningsstudie/ 2025-05-14T08:25:21+00:00 https://www.lmi.no/2025/05/14/oversikt-gsk-har-hoyest-klimagassutslipp-blant-europeiske-legemiddelselskap/ 2025-05-14T08:26:08+00:00 https://www.lmi.no/2025/05/14/nytt-hap-for-gutter-med-duchenne-ny-medisin-naer-godkjenning-i-eu/ 2025-05-14T08:27:37+00:00 https://www.lmi.no/2025/05/14/nye-data-pa-wegovy-effekt-paradoks-nar-man-skal-begynne-a-diskutere-refusjon/ 2025-05-14T08:28:52+00:00 https://www.lmi.no/2025/05/14/novo-nordisk-til-eli-lilly-fedmebehandling-handler-ikke-bare-om-kilo/ 2025-05-14T08:29:50+00:00 https://www.lmi.no/2025/05/14/astra-zeneca-enig-med-trump-om-fordeling-av-kostnader-ved-legemiddelinnovasjon/ 2025-05-14T08:30:36+00:00 https://www.lmi.no/2025/05/14/hva-koster-et-godt-levear-frp-vil-oke-terskelverdien-dmp-advarer/ 2025-05-14T08:31:36+00:00 https://www.lmi.no/2025/05/14/hartapsmedisin-kan-gi-selvmordstanker-na-far-pasientene-en-ekstra-advarsel/ 2025-05-14T08:32:41+00:00 https://www.lmi.no/2025/05/14/bayer-tynges-av-rettsaker-toll-og-usikkerhet/ 2025-05-14T08:33:35+00:00 https://www.lmi.no/2025/05/14/astra-zeneca-far-britisk-godkjenning-for-mer-miljovennlig-inhalator/ 2025-05-14T08:34:24+00:00 https://www.lmi.no/2025/05/14/franskmannen-har-statt-for-flere-milliardoppkjop-vil-bane-vei-for-lytix-suksess/ 2025-05-14T08:35:11+00:00 https://www.lmi.no/2025/05/15/sanofi-vil-investere-20-milliarder-dollar-i-usa/ 2025-05-15T07:27:23+00:00 https://www.lmi.no/2025/05/15/roche-revurderer-milliardinvestering-i-usa-etter-presidentordre/ 2025-05-15T07:28:22+00:00 https://www.lmi.no/2025/05/15/ous-rekrutterer-barn-og-unge-med-inflammatorisk-tarmsykdom-til-kliniske-studier/ 2025-05-15T07:29:30+00:00 https://www.lmi.no/2025/05/15/studie-slankemedisiner-er-ogsa-nyttige-for-barn-med-fedme-i-den-virkelige-verden/ 2025-05-15T07:30:29+00:00 https://www.lmi.no/2025/05/15/astrazeneca-best-i-klasseni-reduserte-klimautslipp/ 2025-05-15T07:32:39+00:00 https://www.lmi.no/2025/05/15/disse-20-legemiddelselskapene-omsatte-for-mest-i-2024/ 2025-05-15T07:33:40+00:00 https://www.lmi.no/2025/05/15/novo-nordisk-inngar-partnerskap-med-amerikansk-biotek-selskap/ 2025-05-15T07:36:10+00:00 https://www.lmi.no/2025/05/15/roche-revurderer-milliardinvestering-i-usa-etter-presidentordre-2/ 2025-05-15T07:37:16+00:00 https://www.lmi.no/2025/05/15/mener-lave-legemiddelpriser-driver-norge-inn-i-et-race-to-the-bottom/ 2025-05-15T07:38:10+00:00 https://www.lmi.no/2025/05/15/lungekreftforeningen-byrakrati-stopper-viktig-kreftbehandling/ 2025-05-15T07:38:59+00:00 https://www.lmi.no/2025/05/15/ny-immunterapi-i-sproyteform-opdivo-kan-bli-innfort-denne-maneden/ 2025-05-15T07:39:50+00:00 https://www.lmi.no/2025/05/15/medwatch-revidert-budsjett-gir-hap-og-hodebry-for-lmi/ 2025-05-15T17:33:45+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-15-193132.png https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-15-193132.png https://www.lmi.no/2025/05/16/trump-gar-etter-legemiddelindustrien-det-vil-vaere-dramatisk/ 2025-05-16T07:43:43+00:00 https://www.lmi.no/2025/05/16/lmi-i-tv2-om-trumps-presidentordre/ 2025-05-16T08:59:05+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Front-TV2-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/05/Front-TV2-kopi.jpg https://www.lmi.no/2025/04/29/oppfordring-til-industrien-korrekt-bruk-av-produktkoder-pa-inneremballasje/ 2025-05-18T18:44:07+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Hetteglass-med-kode-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Hetteglass-med-kode-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Astrid-Johnsen_Sykehuspartner-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/04/Produktkoder-pa-innerpakning.png https://www.lmi.no/2025/05/19/abbvie-mener-usikkerhet-vektes-for-tungt-ikke-i-trad-med-faglige-prinsipper/ 2025-05-19T08:15:21+00:00 https://www.lmi.no/2025/05/19/denne-trump-ordren-kan-ga-utover-deg/ 2025-05-19T08:16:28+00:00 https://www.lmi.no/2025/05/19/helvetesild-%e2%81%a0-kan-ikke-vaere-slik-at-folk-ikke-har-rad-til-a-vaksinere-seg/ 2025-05-19T10:11:40+00:00 https://www.lmi.no/2025/05/19/norsk-forskning-risikerer-mindre-tilgang-til-eu-milliarder/ 2025-05-19T10:12:48+00:00 https://www.lmi.no/2025/05/19/seks-dagar-kortare-ventetid-5-600-000-timar-overtid/ 2025-05-19T10:13:41+00:00 https://www.lmi.no/2025/05/19/novo-nordisk-sjef-lars-fruergaard-jorgensen-gar-av/ 2025-05-19T10:16:09+00:00 https://www.lmi.no/2025/05/19/vil-ekspress-behandle-nytt-legemiddel-mot-atopisk-eksem/ 2025-05-19T10:17:35+00:00 https://www.lmi.no/2025/05/19/forskere-advarer-om-dodelig-sopp-som-sprer-seg-i-europa-millioner-risikerer-livstruende-infeksjoner/ 2025-05-19T10:18:27+00:00 https://www.lmi.no/2025/05/19/debatt-det-er-pa-tide-a-velge-en-bredere-hpv-vaksine-for-norge/ 2025-05-19T10:19:48+00:00 https://www.lmi.no/2025/05/19/arctic-bioscience-far-igjen-for-sparetiltak/ 2025-05-19T10:20:36+00:00 https://www.lmi.no/2025/05/19/boehringer-ingelheim-inn-i-connect/ 2025-05-19T10:21:26+00:00 https://www.lmi.no/2025/05/19/jaypirca-gar-til-metodevurdering-kan-bli-nytt-behandlingsalternativ-for-kll-pasienter/ 2025-05-19T10:22:17+00:00 https://www.lmi.no/2025/05/19/dette-skjer-i-uke-21-supertirsdag-for-helsepolitikerne-og-statsraden-til-geneve/ 2025-05-19T10:23:23+00:00 https://www.lmi.no/2025/05/19/en-stralende-radioterapi-uke-i-oslo/ 2025-05-19T10:40:05+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Radiofarmasi_Auditoriet-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Radiofarmasi_Skilt-Uio-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Radiofarmasi-Rootwelt-Revheim-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Radiofarmasi_Auditoriet-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Radiofarmasi_NorTrials-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Radiofarmasi_Bayer-scaled.jpg https://www.lmi.no/2025/05/20/bestillerforum-sier-nei-ingen-ny-metodevurdering-av-spravato-mot-behandlingsresistent-depresjon/ 2025-05-20T11:50:27+00:00 https://www.lmi.no/2025/05/20/nye-funn-kroppen-kjemper-imot/ 2025-05-20T11:51:13+00:00 https://www.lmi.no/2025/05/20/sju-maneder-gammel-baby-blir-den-forste-som-far-banebrytende-og-helt-personlig-tilpasset-behandling-i-genene-sine/ 2025-05-20T11:52:02+00:00 https://www.lmi.no/2025/05/20/lars-fruergaard-jorgensen-setter-ord-pa-sin-exit-jeg-hadde-ikke-sett-dette-komme/ 2025-05-20T11:53:11+00:00 https://www.lmi.no/2025/05/20/fda-godkjenner-blodprove-til-diagnostisering-av-alzheimers/ 2025-05-20T11:53:53+00:00 https://www.lmi.no/2025/05/20/kreftforeningen-frykter-pasienter-stenges-ute-av-ny-unntaksordning/ 2025-05-20T11:54:49+00:00 https://www.lmi.no/2025/05/20/norge-ma-vaere-med-nar-norden-tar-ledertroya-innen-livsvitenskap/ 2025-05-20T12:07:55+00:00 https://www.lmi.no/wp-content/uploads/2025/05/LSX-Nordic-2025.jpg https://www.lmi.no/wp-content/uploads/2025/05/LSX-Nordic-2025.jpg https://www.lmi.no/2025/05/20/dmps-forslag-til-prisrevurderingsrekkefolge-for-2026/ 2025-05-20T14:01:01+00:00 https://www.lmi.no/wp-content/uploads/2020/08/Penger-legemidler-scaled.jpeg https://www.lmi.no/2025/05/21/professor-jan-terje-andersen-tildelt-uios-innovasjonspris-for-2025/ 2025-05-21T10:12:01+00:00 https://www.lmi.no/2025/05/21/slar-alarm-om-beredskapen-det-er-naivt/ 2025-05-21T10:34:10+00:00 https://www.lmi.no/2025/05/21/studie-norsk-hjertesvikt-strategi-lykkes/ 2025-05-21T10:35:07+00:00 https://www.lmi.no/2025/05/21/skal-samarbeide-tettere-med-eu-om-helse-og-forsvar/ 2025-05-21T10:35:53+00:00 https://www.lmi.no/2025/05/21/norsk-teknologi-fra-exact-therapeutics-ga-firedoblet-effekt-av-cellegift-mot-leverkreft/ 2025-05-21T10:36:37+00:00 https://www.lmi.no/2025/05/21/status-for-lmis-strategiarbeid/ 2025-05-21T10:53:31+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Thordis-Widvey-Haugen-6012-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Thordis-Widvey-Haugen-6012-scaled.jpg https://www.lmi.no/2025/05/22/tollere-fant-ulovlige-medisiner-livsfarlig/ 2025-05-22T08:14:07+00:00 https://www.lmi.no/2025/05/22/helseokonom-mener-helseministeren-apner-for-mer-tilfeldigheter-i-beslutningsforum/ 2025-05-22T08:15:14+00:00 https://www.lmi.no/2025/05/22/uenige-om-qaly-metodikken-fanger-opp-relevante-aspekter-ved-sjelden-sykdom/ 2025-05-22T08:16:14+00:00 https://www.lmi.no/2025/05/22/opplaering-i-legemiddelhandtering-et-stort-skritt-fremover/ 2025-05-22T08:17:19+00:00 https://www.lmi.no/2025/05/22/debatt-kan-helseministeren-akseptere-at-en-hel-pasientgruppe-feilprioriteres/ 2025-05-22T08:18:28+00:00 https://www.lmi.no/2025/05/22/dette-er-norges-dyreste-legemidler/ 2025-05-22T08:19:44+00:00 https://www.lmi.no/2025/05/22/tiarets-storste-gjennombrudd-for-blaerekreft-pasienter-kan-fa-ja-i-norge-pa-mandag/ 2025-05-22T08:20:54+00:00 https://www.lmi.no/2025/05/22/nyttig-mote-med-sykehusapotekene-om-kliniske-studier/ 2025-05-22T10:58:31+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Mote-med-sykehusapotekene-4.png https://www.lmi.no/wp-content/uploads/2025/05/Mote-med-sykehusapotekene-4.png https://www.lmi.no/wp-content/uploads/2025/05/Kari-Heimholt.jpeg https://www.lmi.no/wp-content/uploads/2024/09/Ina-Dahlsveen-crop-1.png https://www.lmi.no/2025/05/22/har-lansert-nordisk-veikart-for-sjeldne-diagnoser/ 2025-05-22T11:25:37+00:00 https://www.lmi.no/2025/05/22/flere-land-oker-bidragene-sine-til-who-etter-usa-exit/ 2025-05-22T11:26:42+00:00 https://www.lmi.no/2025/05/22/radgivere-og-analytikere-mener-det-kan-komme-oppsigelser-i-novo-nordisk/ 2025-05-22T11:27:37+00:00 https://www.lmi.no/2025/05/22/feil-med-dmps-journalsystem-rettet-opp-i-etter-to-maneder/ 2025-05-22T11:28:41+00:00 https://www.lmi.no/2025/05/23/industri-og-myndigheter-styrker-det-regulatoriske-samarbeidet-i-norden/ 2025-05-23T08:55:10+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Bente-og-Linn-Camilla-Island-2025_edited-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Nordisk-regulatorysamarbeid-Island-2025_edited-scaled.jpg https://www.lmi.no/2025/05/26/fortsatt-mulig-a-melde-seg-pa-reklamekurs/ 2025-05-26T08:43:20+00:00 https://www.lmi.no/wp-content/uploads/2019/02/Reklamekurs_digforside2019_uten-tekst.jpg https://www.lmi.no/2025/05/26/ni-metoder-pa-beslutningsforums-bord-i-mai/ 2025-05-26T10:03:41+00:00 https://www.lmi.no/2025/05/23/clinical-trials-day-2025-ble-markert-i-bergen/ 2025-05-26T10:05:00+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Clinical-Trials-Day-2025_auditoriet-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/05/Clinical-Trials-Day-2025_auditoriet-scaled.jpg https://www.lmi.no/2025/05/26/lilly-soker-blaresept-for-mounjaro-et-ja-kan-koste-staten-milliarder/ 2025-05-26T10:18:13+00:00 https://www.lmi.no/2025/05/26/nykode-skal-ha-to-postere-pa-asco/ 2025-05-26T10:19:18+00:00 https://www.lmi.no/2025/05/26/kristin-38-har-selvmordshodepine-men-far-ikke-tak-i-godkjent-behandling/ 2025-05-26T10:20:48+00:00 https://www.lmi.no/2025/05/26/chmp-anbefaler-godkjennelse-av-ti-nye-legemidler/ 2025-05-26T10:22:47+00:00 https://www.lmi.no/2025/05/26/saken-vil-bli-en-betydelig-stresstest-for-beslutningsforum/ 2025-05-26T10:24:14+00:00 https://www.lmi.no/2025/05/26/lege-kritisk-til-migrenepraksis-de-saboterer-stortingsvedtaket/ 2025-05-26T10:25:31+00:00 https://www.lmi.no/2025/05/26/dette-skjer-i-uke-22-innspurt-pa-stortinget-og-den-nye-abortloven-trer-i-kraft/ 2025-05-26T10:26:32+00:00 https://www.lmi.no/2025/05/26/danske-prisforhandlinger-pa-apoteklegemidler-sykehusinnkjop-sier-velkommen-etter/ 2025-05-26T10:27:38+00:00 https://www.lmi.no/2025/05/26/regulatorisk-hostmote-23-oktober/ 2025-05-26T11:38:04+00:00 https://www.lmi.no/wp-content/uploads/2021/11/Regulatorisk-hostmote-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/11/Regulatorisk-hostmote-2-scaled.jpg https://www.lmi.no/2025/05/26/lmi-dagen-under-arendalsuka-2025/ 2025-05-26T11:41:49+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Arendal-Adobe-stock-1280x852.jpeg https://www.lmi.no/2025/05/26/enighet-men-ikke-flertall-i-stortinget-for-livsvitenskapsstrategi/ 2025-05-26T12:01:36+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-26-130819.png https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-26-130819.png https://www.lmi.no/2025/05/26/ny-rapport-kostnaden-for-a-utvikle-legemiddel-oker/ 2025-05-26T13:47:37+00:00 https://www.lmi.no/wp-content/uploads/2024/02/LMI-generelt-med-stortingGF2024.jpg https://www.lmi.no/wp-content/uploads/2024/02/LMI-generelt-med-stortingGF2024.jpg https://www.lmi.no/2025/05/27/ut-mot-cellegift-pastander-%e2%81%a0-oppgitt-og-irritert/ 2025-05-27T08:13:57+00:00 https://www.lmi.no/2025/05/27/msd-tapte-i-tingretten-vaksineanbud-gjenapnes-ikke/ 2025-05-27T08:14:53+00:00 https://www.lmi.no/2025/05/27/medlemsmote-om-prioriteringsmeldingen/ 2025-05-27T13:28:55+00:00 https://www.lmi.no/wp-content/uploads/2024/11/front-medlemsmote-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/11/front-medlemsmote-kopi.jpg https://www.lmi.no/2025/05/28/debatt-stortinget-kan-sikre-at-prioriteringsmeldingen-kan-mote-den-medisinske-utviklingen/ 2025-05-28T10:24:10+00:00 https://www.lmi.no/2025/05/28/pandemiavtalen-vi-ikke-har-rad-til-a-mislykkes-med/ 2025-05-28T10:26:11+00:00 https://www.lmi.no/2025/05/28/nho-geneo-oppretter-nytt-bransjenettverk/ 2025-05-28T10:27:35+00:00 https://www.lmi.no/2025/05/28/siv-jensen-far-styreverv-i-kreftforeningen/ 2025-05-28T10:28:31+00:00 https://www.lmi.no/2025/05/28/astra-zenecas-imfinzi-anbefales-godkjent-for-blaerekreft/ 2025-05-28T10:29:40+00:00 https://www.lmi.no/2025/05/28/ms-syke-i-skvis-tvinges-til-krigshissig-nabo-for-a-bli-friske/ 2025-05-28T10:30:35+00:00 https://www.lmi.no/2025/05/28/msd-tapte-vaksine-rettsak-situasjonen-kunne-vaert-unngatt/ 2025-05-28T10:31:42+00:00 https://www.lmi.no/2025/05/28/tommel-opp-til-blenrep-kan-endre-behandlings-landskapet-for-myelomatose/ 2025-05-28T10:33:34+00:00 https://www.lmi.no/2025/05/28/kinesisk-selskap-gar-pa-hong-kong-borsen-vil-konkurrere-mot-novo-nordisk-og-eli-lilly/ 2025-05-28T10:34:44+00:00 https://www.lmi.no/2025/05/28/asco-2025-norske-leger-presenterer-forskning-pa-verdens-storste-kreftkongress/ 2025-05-28T10:35:41+00:00 https://www.lmi.no/2025/03/31/pakningsvedlegg-pa-papir-er-forhistorisk/ 2025-05-28T10:55:44+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Dino1_Landingsside.png https://www.lmi.no/wp-content/uploads/2025/03/Dino1_Landingsside.png https://www.lmi.no/wp-content/uploads/2025/04/Hai_Landingsside-2.png https://www.lmi.no/wp-content/uploads/2025/03/Dino2_Landingsside.png https://www.lmi.no/2025/05/28/flere-seire-for-lmi-i-innstillingen/ 2025-05-28T11:05:07+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Barbara-priomeldingen-2.png https://www.lmi.no/wp-content/uploads/2025/05/Barbara_Leif-Rune-og-priomeldingen.png https://www.lmi.no/2025/05/27/lmi-i-medwatch-stortinget-kan-sikre-at-prioriteringsmeldingen-kan-mote-den-medisinske-utviklingen/ 2025-05-28T11:09:14+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-28-130502.png https://www.lmi.no/wp-content/uploads/2025/05/Skjermbilde-2025-05-28-130502.png https://www.lmi.no/2025/05/28/stortinget-ber-regjeringen-justere-alternativkostnaden/ 2025-05-28T13:09:06+00:00 https://www.lmi.no/wp-content/uploads/2025/05/Barbara-priomeldingen-2.png https://www.lmi.no/2025/05/30/stortinget-med-tydelig-krav-regjeringen-ma-utrede-ny-alternativkostnad/ 2025-05-30T09:03:02+00:00 https://www.lmi.no/2025/05/30/vasvik-ap-advarer-reell-fare-at-vi-ikke-far-flere-legemidler-bare-dyrere/ 2025-05-30T09:04:41+00:00 https://www.lmi.no/2025/05/30/spetalen-ute-av-vistin-pharma-styret/ 2025-05-30T09:05:36+00:00 https://www.lmi.no/2025/05/30/anne-margrethe-hausken-nordberg-kan-delta-i-vm-hvis-hun-vil/ 2025-05-30T09:06:37+00:00 https://www.lmi.no/2025/05/30/kaller-medisinske-tidsskrifter-korrupte/ 2025-05-30T09:07:42+00:00 https://www.lmi.no/2025/06/02/opptak-av-medlemsmotet-om-prioriteringsmeldingen/ 2025-06-02T11:05:18+00:00 https://www.lmi.no/wp-content/uploads/2024/11/front-medlemsmote-kopi.jpg https://www.lmi.no/2025/06/02/forskere-har-laget-malariakur-til-mygg-spennende-og-nytt/ 2025-06-02T11:07:15+00:00 https://www.lmi.no/2025/06/02/novo-nordisk-vil-ikke-gi-detaljer-om-naturprosjekter/ 2025-06-02T11:09:25+00:00 https://www.lmi.no/2025/06/02/sigrid-matthes-er-ny-leder-i-blodkreftforeningen/ 2025-06-02T11:10:22+00:00 https://www.lmi.no/2025/05/30/msd-norge-direktoren-slutter/ 2025-06-02T11:12:20+00:00 https://www.lmi.no/2025/06/02/skuffende-resultat-av-studie-pa-adc-ved-lungekreft/ 2025-06-02T11:13:35+00:00 https://www.lmi.no/2025/06/02/denne-gruppen-har-fire-ganger-hoyere-risiko-for-a-do/ 2025-06-02T11:14:29+00:00 https://www.lmi.no/2025/06/02/legemiddelselskapet-trakk-godkjenningssoknad-etter-asco-studie/ 2025-06-02T11:16:16+00:00 https://www.lmi.no/2025/06/02/norsk-kirurg-pa-asco-vi-kan-ikke-anbefale-denne-pasientgruppen-a-begynne-med-aspirin/ 2025-06-02T11:17:05+00:00 https://www.lmi.no/2025/06/02/betennelsesdempende-medisiner-kan-hjelpe-virus-med-a-spre-seg/ 2025-06-02T11:18:02+00:00 https://www.lmi.no/2025/06/02/vaksinen-kan-gi-lavere-demens-risiko-nesten-ingen-har-tatt-den/ 2025-06-02T11:19:26+00:00 https://www.lmi.no/2025/06/02/ny-kombinasjonsbehandling-reduserer-risiko-for-sykdomsprogresjon-med-35-hos-brystkreftpasienter/ 2025-06-02T11:20:36+00:00 https://www.lmi.no/2025/06/02/hod-etter-msd-klage-utsettelse-hadde-forsinket-vaksinasjonsprogrammet/ 2025-06-02T11:21:56+00:00 https://www.lmi.no/2025/06/01/diskuterte-dansk-norsk-samarbeid-om-innovasjon/ 2025-06-02T12:31:01+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Mingel-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Alle-samlet-utenfor-ambassaden-datadrevet-forskning-demens-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Katja-Nordgaard-Norges-ambassador-til-Danmark-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Per-Morten-Sandset-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Christine-Wergeland-Oslo-Science-City-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Monica-Larsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Salen-scaled.jpg https://www.lmi.no/2025/06/03/staende-applaus-etter-treningsstudie-hvis-et-medikament-hadde-gitt-den-effekten-hadde-det-vaert-overalt/ 2025-06-03T06:44:24+00:00 https://www.lmi.no/2025/06/03/lungekreft-studie-bedring-fra-ti-maneder-til-15-maneder/ 2025-06-03T06:45:26+00:00 https://www.lmi.no/2025/06/03/moderna-far-godkjent-ny-koronavaksine-til-eldre/ 2025-06-03T06:46:17+00:00 https://www.lmi.no/2025/06/03/sanofi-kjoper-amerikansk-selskap-for-over-90-milliarder-kroner/ 2025-06-03T06:47:05+00:00 https://www.lmi.no/2025/06/02/leverandorene-vil-fa-okende-krav-om-reduksjon-av-co2-utslipp/ 2025-06-03T06:56:41+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Gronn-helsetjeneste_AdobeStock_AI-generert-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/06/Gronn-helsetjeneste_AdobeStock_AI-generert-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/06/Veronica-Gran-_portrett-2.jpg https://www.lmi.no/wp-content/uploads/2025/06/Anne-Margrethe-Hausken-Nordberg_portrett-2.jpg https://www.lmi.no/2025/06/03/astra-zeneca-vil-eliminere-kreft-som-dodsarsak/ 2025-06-03T09:45:47+00:00 https://www.lmi.no/2025/06/03/enhertu-kan-bli-ny-forstelinjestandard-ved-her2-positiv-brystkreft/ 2025-06-03T09:46:47+00:00 https://www.lmi.no/2025/06/04/pasientorganisasjoner-raser-mot-ventetidstatistikk-ma-males-til-faktisk-tilgang/ 2025-06-04T12:18:50+00:00 https://www.lmi.no/wp-content/uploads/2025/06/HT-pasientforeninger.png https://www.lmi.no/wp-content/uploads/2025/06/HT-pasientforeninger.png https://www.lmi.no/2025/06/04/sykehusinnkjop-vil-skjerpe-klimakrav-til-leverandorer/ 2025-06-04T13:23:54+00:00 https://www.lmi.no/2025/06/04/superbakterier-sprer-seg-%e2%81%a0-det-er-bekymringsfullt/ 2025-06-04T13:24:49+00:00 https://www.lmi.no/2025/06/04/debatt-norge-trenger-en-nasjonal-livsvitenskapsstrategi/ 2025-06-04T13:26:34+00:00 https://www.lmi.no/2025/06/04/debatt-fra-rekordlange-ventetider-til-tidlig-tilgang/ 2025-06-04T13:28:26+00:00 https://www.lmi.no/2025/06/04/pasientorganisasjoner-raser-mot-ventetidstatistikk-ma-males-til-faktisk-tilgang-2/ 2025-06-04T13:29:13+00:00 https://www.lmi.no/2025/06/04/debatt-norge-trenger-en-nasjonal-livsvitenskapsstrategi-2/ 2025-06-04T13:33:16+00:00 https://www.lmi.no/wp-content/uploads/2025/06/MedW-innlegg.png https://www.lmi.no/wp-content/uploads/2025/06/MedW-innlegg.png https://www.lmi.no/2025/06/05/eus-medisinsjef-mener-uenighet-om-nye-medisiner-er-positivt/ 2025-06-05T09:27:21+00:00 https://www.lmi.no/2025/06/05/helsevalget-2025-truls-vasvik-ap-om-prioriteringsmeldingen-terskelverdi-og-helsekoer/ 2025-06-05T09:28:09+00:00 https://www.lmi.no/2025/06/05/kreftpasienter-i-storbritannia-rammes-av-medisinmangel-%e2%81%a0-veldig-alvorlig/ 2025-06-05T09:28:34+00:00 https://www.lmi.no/2025/06/05/hadde-hapet-pa-modigere-tiltak/ 2025-06-05T10:33:56+00:00 https://www.lmi.no/wp-content/uploads/2025/06/medwatch-legis.png https://www.lmi.no/wp-content/uploads/2025/06/medwatch-legis.png https://www.lmi.no/2025/06/10/hadde-hapet-pa-modigere-tiltak-2/ 2025-06-10T07:56:29+00:00 https://www.lmi.no/2025/06/10/alvorlig-medisinmangel-rammer-hele-europa/ 2025-06-10T07:58:08+00:00 https://www.lmi.no/2025/06/10/trump-har-rett-amerikanerne-sponser-var-tilgang-pa-nye-legemidler/ 2025-06-10T07:59:08+00:00 https://www.lmi.no/2025/06/10/immunterapi-i-sproyteform-eu-godkjenner-subkutan-opdivo/ 2025-06-10T08:00:07+00:00 https://www.lmi.no/2025/06/10/norge-vurderer-nytt-eu-regelverk-for-legemidler-vil-folge-utviklingen-noye/ 2025-06-10T08:04:50+00:00 https://www.lmi.no/2025/06/10/debatt-sterkt-og-viktig-signal-fra-helseministeren-vil-ha-mer-legemiddelsamarbeid-pa-tvers-i-norden/ 2025-06-10T08:05:07+00:00 https://www.lmi.no/2025/06/10/ny-kreftmedisin-splitter-legene-helt-uforsvarlig/ 2025-06-10T08:06:25+00:00 https://www.lmi.no/2025/06/10/eus-legemiddelreform-viktig-og-vanskelig-a-stimulere-til-innovasjon-og-baerekraftige-priser/ 2025-06-10T08:07:15+00:00 https://www.lmi.no/2025/06/10/gir-stotte-til-11-doktorgradsprosjekter-i-helsenaeringen/ 2025-06-10T08:08:18+00:00 https://www.lmi.no/2025/06/10/harvard-rapport-viser-at-kina-kan-overta-usa-i-bioteknologi/ 2025-06-10T08:09:08+00:00 https://www.lmi.no/2025/06/10/sverige-vil-produsere-egen-antibiotika/ 2025-06-10T08:11:07+00:00 https://www.lmi.no/2025/06/10/hemispherian-far-orphan-drug-status-i-europa/ 2025-06-10T08:30:43+00:00 https://www.lmi.no/2025/06/10/kampen-om-fettet/ 2025-06-10T08:54:13+00:00 https://www.lmi.no/2025/06/10/kronikk-norsk-livsvitenskap-mer-enn-bare-helse/ 2025-06-10T08:57:48+00:00 https://www.lmi.no/2025/06/10/forskning-slankemedisin-kan-forebygge-alvorlig-sykdom/ 2025-06-10T08:58:37+00:00 https://www.lmi.no/2025/06/10/pasientorganisasjoner-krever-ny-ventetidsmaling-statsekretaer-peker-pa-industrien/ 2025-06-10T08:59:44+00:00 https://www.lmi.no/2025/06/10/roche-far-eu-godkjenning-for-en-tablett-til-behandling-av-sma/ 2025-06-10T09:00:31+00:00 https://www.lmi.no/2025/06/10/meld-deg-pa-nls-days-2025/ 2025-06-10T09:31:49+00:00 https://www.lmi.no/wp-content/uploads/2024/10/NLSD24-Design-1_1200x627px.png https://www.lmi.no/wp-content/uploads/2025/06/NLSD24-Design-1_1200x627px.png https://www.lmi.no/2025/06/11/nordmenn-presenterer-blodkreftforskning-pa-europeisk-kongress/ 2025-06-11T09:32:30+00:00 https://www.lmi.no/2025/06/11/innkjop-i-en-urolig-verden-bra-at-helsepersonell-engasjerer-seg/ 2025-06-11T09:33:31+00:00 https://www.lmi.no/2025/06/11/har-okt-i-flere-ar-na-har-det-skjedd-en-uforklarlig-utvikling/ 2025-06-11T10:29:36+00:00 https://www.lmi.no/2025/06/11/novo-nordisk-starter-ny-studie-pa-legemiddelkandidat-mot-fedme/ 2025-06-11T10:30:26+00:00 https://www.lmi.no/2025/06/11/vurderer-oyesykdom-som-svaert-sjelden-bivirkning/ 2025-06-11T10:31:52+00:00 https://www.lmi.no/2025/06/11/kommentar-ventetiden-vi-ikke-vil-telle/ 2025-06-11T10:33:27+00:00 https://www.lmi.no/2025/06/11/pfizer-haper-prispress-i-usa-vil-gi-okte-legemiddelpriser-i-europa/ 2025-06-11T10:35:34+00:00 https://www.lmi.no/2025/06/11/informasjonsmote-om-htar/ 2025-06-11T13:04:18+00:00 https://www.lmi.no/wp-content/uploads/2025/06/European-Union-EU-and-the-European-Commission-1.jpg https://www.lmi.no/2025/06/12/barn-skal-fa-slankesproyter-dette-haper-forskerne-a-avdekke/ 2025-06-12T07:48:57+00:00 https://www.lmi.no/2025/06/12/fda-godkjenning-av-msd-legemiddel-oker-konkurransen-i-rsv-markedet/ 2025-06-12T07:49:48+00:00 https://www.lmi.no/2025/06/12/novo-nordisk-inngar-lisensavtale-med-amerikansk-bioteknologiselskap/ 2025-06-12T07:51:01+00:00 https://www.lmi.no/2025/06/12/lmi-motte-helseministeren-om-tilgang/ 2025-06-12T10:48:37+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Design-uten-navn-1.jpg https://www.lmi.no/wp-content/uploads/2025/06/Design-uten-navn-1.jpg https://www.lmi.no/2023/12/20/hver-eneste-laks-er-vaksinert/ 2025-06-12T11:25:46+00:00 https://www.lmi.no/wp-content/uploads/2023/09/66A2719-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2770-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2110-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2593-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2854-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2094-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2719-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2677-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2698-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2656-scaled.jpg https://www.lmi.no/2025/03/03/fra-botter-med-antibiotika-til-revolusjonerende-fiskevaksiner/ 2025-06-12T11:43:59+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Etikettering-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Dag-Knappskog_foto-blue-analytics.jpg https://www.lmi.no/wp-content/uploads/2025/03/Petter-Frost_foto-Bioteknologiradet-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Manemenn-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Tonner-pa-lab-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Dag-Knappskog_rett-vei-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Fiskevaksinefigur.png https://www.lmi.no/wp-content/uploads/2025/03/Etikettering-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/03/Laks-scaled.jpeg https://www.lmi.no/2024/04/25/ilab-sorger-for-at-forskning-pa-fiskevaksiner-og-medisiner-kan-gjores-i-norge/ 2025-06-12T11:44:19+00:00 https://www.lmi.no/wp-content/uploads/2024/04/ilab-og-msd-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/ilab-og-msd-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Reidar-i-lab-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/ilab-Leif-Rune-kikker-inn-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/ilab-pharmaq-omvisning-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/ilab-yngelkasser-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/ilab-rogn-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/ilab-yngel-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Ilab-ras-omvisning-scaled.jpg https://www.lmi.no/2024/05/08/virusfabrikken-pa-klofta-produserer-for-fullt/ 2025-06-12T11:44:38+00:00 https://www.lmi.no/wp-content/uploads/2024/05/skjermbilde-virusvideo-pharmaq.png https://www.lmi.no/wp-content/uploads/2024/05/Pharmaq-Klofta-besok-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Pharmaq-testskaler.jpg https://www.lmi.no/wp-content/uploads/2024/05/Pharmaq-klofta-produksjon-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Cellefabrikk.jpg https://www.lmi.no/wp-content/uploads/2024/05/Pharmaq-Overforer-celler.jpg https://www.lmi.no/2024/04/02/norske-pharmaq-sorger-for-trygg-mat-til-verden/ 2025-06-12T11:44:55+00:00 https://www.lmi.no/wp-content/uploads/2024/04/Pharmaq-gruppa-pa-omvisning-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Pharmaq-gruppa-pa-omvisning-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Pharmaq-ren-sone-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2719-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Pharmaq-Trude-og-Thomas-scaled.jpg https://www.lmi.no/2025/06/13/scann-koden-og-finn-willy/ 2025-06-13T09:05:05+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Skjermbilde-podkasten-kvallm.png https://www.lmi.no/wp-content/uploads/2025/06/Dino1.png https://www.lmi.no/wp-content/uploads/2025/06/Skjermbilde-podkasten-kvallm.png https://www.lmi.no/2025/06/13/debatt-antibiotikaresistens-krever-nytenkning-laer-av-norsk-oljepolitikk/ 2025-06-13T10:14:51+00:00 https://www.lmi.no/2025/06/13/slik-forhandler-norge-frem-prisen-pa-nye-legemidler/ 2025-06-13T10:15:49+00:00 https://www.lmi.no/2025/06/16/dette-kan-halvere-risikoen-for-tilbakefall-av-vanlig-kreftform-%e2%81%a0-aldri-sett-noe-lignende/ 2025-06-16T09:49:57+00:00 https://www.lmi.no/2025/06/16/novo-nordisk-leder-med-en-harsbredd-er-na-det-mest-verdifulle-selskapet-i-europa/ 2025-06-16T09:50:55+00:00 https://www.lmi.no/2025/06/16/kml-pasienter-fikk-faerre-bivirkninger-og-raskere-effekt-kan-bli-ny-forstelinjebehandling/ 2025-06-16T09:51:51+00:00 https://www.lmi.no/2025/06/16/blodkreft-medisiner-oker-behovet-for-immunglobuliner-mot-immunsvikt-det-skaper-store-utfordringer/ 2025-06-16T09:52:46+00:00 https://www.lmi.no/2025/06/16/bayer-slar-forventninger-tjener-mer-penger-pa-legemiddelvirksomheten/ 2025-06-16T10:08:18+00:00 https://www.lmi.no/2025/06/16/tar-til-orde-for-leterefusjon-for-utvikling-av-antibiotika/ 2025-06-16T10:09:33+00:00 https://www.lmi.no/2025/06/16/ny-studie-stotter-enklere-oyeoppfolging-av-pasienter-med-benmargskreft/ 2025-06-16T10:11:27+00:00 https://www.lmi.no/2025/06/16/haper-a-kunne-forutsi-hvordan-kml-pasienter-responderer-pa-behandling-etter-kun-en-time/ 2025-06-16T10:12:18+00:00 https://www.lmi.no/2025/06/16/eu-kommisjonen-godkjenner-behandling-for-duchennes-muskeldystrofi/ 2025-06-16T10:13:24+00:00 https://www.lmi.no/2025/06/16/pelabresib-viser-varig-effekt-ved-myelofibrose-kan-bli-forste-nye-behandling-pa-over-ti-ar/ 2025-06-16T10:14:48+00:00 https://www.lmi.no/2025/06/16/jakten-pa-en-hiv-kur-%e2%81%a0-et-skikkelig-gjennombrudd/ 2025-06-16T10:15:44+00:00 https://www.lmi.no/2025/06/16/alle-benmargskreft-pasientene-fikk-effekt-av-ny-antistoff-behandling-den-storste-eha-nyheten/ 2025-06-16T10:16:39+00:00 https://www.lmi.no/2025/06/16/neste-generasjons-legemidler-gir-hap-for-kll-pasienter/ 2025-06-16T10:17:27+00:00 https://www.lmi.no/2025/06/16/lovende-kombinasjon-mot-tilbakevendende-benmargskreft-veldig-spennende/ 2025-06-16T10:18:11+00:00 https://www.lmi.no/2025/06/16/ny-studie-tidsbegrenset-behandling-gir-bedre-overlevelse-ved-kll-na-innfort-i-norge/ 2025-06-16T10:18:58+00:00 https://www.lmi.no/2025/06/16/mantelcellelymfom-seks-av-ti-pasienter-ble-kreftfrie-med-malrettet-behandling/ 2025-06-16T10:20:43+00:00 https://www.lmi.no/2025/06/16/ny-oppdagelse-en-av-fremtidens-kreftbehandlinger-kan-gjemme-seg-pa-havets-bunn/ 2025-06-16T10:21:44+00:00 https://www.lmi.no/2025/06/17/amerikansk-biotek-aksje-stuper-etter-pasientdodsfall/ 2025-06-17T08:52:44+00:00 https://www.lmi.no/2025/06/17/sanofi-far-reklamesmekk-fra-dmp-og-eget-bransjerad/ 2025-06-17T08:53:38+00:00 https://www.lmi.no/2025/06/17/ulik-effekt-av-slankemedisiner-hos-kvinner-og-menn-har-ikke-fatt-nok-oppmerksomhet/ 2025-06-17T08:54:33+00:00 https://www.lmi.no/2025/06/17/feiret-den-lille-farmasoyten-med-det-store-fotavtrykket/ 2025-06-17T08:55:31+00:00 https://www.lmi.no/2025/06/17/beslutningsforum-innforer-15-nye-metoder-norge-forst-med-tre-kreftbehandlinger/ 2025-06-17T08:56:31+00:00 https://www.lmi.no/2025/06/17/inngar-ki-samarbeid-verdt-milliarder/ 2025-06-17T08:57:44+00:00 https://www.lmi.no/2025/06/17/feiret-inspire-prosjektet-en-skattekiste-av-livsviktig-informasjon/ 2025-06-17T11:26:55+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Inspire-avslutning-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Inspire-avslutning-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/inspire-avslutning2_edited-scaled.jpg https://www.lmi.no/2025/06/18/eli-lilly-kjoper-biotek-selskap-for-12-milliarder-kroner/ 2025-06-18T08:14:22+00:00 https://www.lmi.no/2025/06/18/ny-norden-sjef-for-gilead-sciences/ 2025-06-18T08:15:57+00:00 https://www.lmi.no/2025/06/18/trump-varsler-legemiddeltoll-veldig-snart/ 2025-06-18T08:16:44+00:00 https://www.lmi.no/2025/06/18/kvinner-har-bedre-effekt-av-slankemedisin-mekanismene-er-ikke-fullt-ut-forstatt/ 2025-06-18T08:17:39+00:00 https://www.lmi.no/2025/06/18/kll-pasienter-fikk-bedre-livskvalitet-med-ny-btk-hemmer/ 2025-06-18T08:18:27+00:00 https://www.lmi.no/2025/06/18/oncoinvent-med-sterke-data-for-ny-behandling-overgar-forventningene/ 2025-06-18T08:19:33+00:00 https://www.lmi.no/2025/06/19/abbvies-kreftlegemiddel-mislykkes-i-fase-3-kombinasjonsstudie/ 2025-06-19T09:32:57+00:00 https://www.lmi.no/2025/06/19/kronikk-tenk-om-vi-hadde-satset-pa-antibiotika-fremfor-batterifabrikker/ 2025-06-19T09:34:34+00:00 https://www.lmi.no/2025/06/19/ny-kombinasjonsbehandling-viser-lovende-effekt-ved-tilbakevendende-kll/ 2025-06-19T09:35:42+00:00 https://www.lmi.no/2025/06/19/glemte-a-betale-avgift-novo-nordisk-mister-snart-patentbeskyttelse-i-canada/ 2025-06-19T09:36:40+00:00 https://www.lmi.no/2025/06/19/beslutningsforum-videreforer-luxturna-genterapi-for-sjelden-oyesykdom-far-varig-godkjenning/ 2025-06-19T09:37:39+00:00 https://www.lmi.no/2025/06/19/lanserte-nye-tiltak-for-handtering-av-usikkerhet/ 2025-06-19T09:44:41+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Image-2.jpg https://www.lmi.no/2025/06/23/debatt-nar-systemet-ikke-ser-hele-bildet-blindsoner-i-metodevurderingene/ 2025-06-23T09:17:19+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Barb-blindsoner-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/06/Barb-blindsoner-kopi.jpg https://www.lmi.no/2025/06/23/healthtalk-lmi-om-bekengs-pekefinger-mot-industrien-ren-ansvarsfraskrivelse/ 2025-06-23T09:20:54+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Barb-HT-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/06/Barb-HT-kopi.jpg https://www.lmi.no/2025/06/23/dmp-gar-ut-med-advarsel-mot-nad-som-foryngelseskur/ 2025-06-23T10:27:29+00:00 https://www.lmi.no/2025/06/23/eli-lilly-anker-refusjons-nei-for-alzheimer-medisin-i-storbritannia/ 2025-06-23T10:30:31+00:00 https://www.lmi.no/2025/06/23/paradigmeskifte-i-blodkreft-behandling-vi-kan-komme-til-a-snakke-om-kurasjon/ 2025-06-23T10:31:30+00:00 https://www.lmi.no/2025/06/23/debatt-nar-systemet-ikke-ser-hele-bildet-blindsoner-i-metodevurderingene-2/ 2025-06-23T10:33:50+00:00 https://www.lmi.no/2025/06/23/beroliger-ansatte-styret-leter-etter-en-erstatter-med-novo-nordisk-verdier/ 2025-06-23T10:34:39+00:00 https://www.lmi.no/2025/06/23/lmi-om-bekengs-pekefinger-mot-industrien-ren-ansvarsfraskrivelse/ 2025-06-23T10:35:34+00:00 https://www.lmi.no/2025/06/23/studie-trippel-dose-av-wegovy-ga-storre-vektnedgang/ 2025-06-23T10:36:31+00:00 https://www.lmi.no/2025/06/23/kronikk-det-finnes-legemidler-som-vil-fa-flere-i-jobb-helt-gratis/ 2025-06-23T10:38:13+00:00 https://www.lmi.no/2025/06/23/sterk-start-for-mounjaro-i-india/ 2025-06-23T10:39:42+00:00 https://www.lmi.no/2025/06/23/takker-av-etter-12-ar-pa-stortinget-na-skal-han-jobbe-med-legemidler/ 2025-06-23T10:40:50+00:00 https://www.lmi.no/2025/06/23/even-9-lever-pa-overtid-familien-kjempar-for-a-redde-andre-barn/ 2025-06-23T10:41:56+00:00 https://www.lmi.no/2025/06/23/operasjon-eller-slankemedisin-et-av-alternativene-ga-mye-storre-vekttap/ 2025-06-23T10:43:57+00:00 https://www.lmi.no/2025/06/23/novo-nordisk-la-frem-studieresultater-pa-nytt-vekttapshap/ 2025-06-23T10:45:07+00:00 https://www.lmi.no/2025/06/24/eksport-er-et-verdensmesterskap/ 2025-06-24T11:31:15+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Christian-Chramer_edited-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Christian-Chramer_edited-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Sushi_AdobeStock_46851856-scaled.jpeg https://www.lmi.no/2021/04/06/slik-kan-norge-bli-verdensledende-pa-virus-som-dreper-bakterier/ 2025-06-24T12:39:27+00:00 https://www.lmi.no/wp-content/uploads/2021/04/erna-og-co.jpg https://www.lmi.no/wp-content/uploads/2021/04/erna-og-co.jpg https://www.lmi.no/wp-content/uploads/2021/04/rapporten.jpg https://www.lmi.no/wp-content/uploads/2021/04/bakteriofagfabrikk-under-bygging-scaled.jpg https://www.lmi.no/2025/06/24/tilgang-pa-legemidler-fra-israel/ 2025-06-25T05:59:28+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Israel-legemidler-AdobeStock_411665737-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/06/Israel-legemidler-AdobeStock_411665737-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/06/Kristine-Romoren_DMP.jpg https://www.lmi.no/2025/06/25/eli-lilly-forventer-resultater-fra-fedmekandidat-i-tredje-kvartal/ 2025-06-25T07:53:17+00:00 https://www.lmi.no/2025/06/25/norge-som-referanseland-potensialet-i-helsedata-og-offentlig-privat-samarbeid/ 2025-06-25T07:54:25+00:00 https://www.lmi.no/2025/06/25/slik-endret-koronapandemien-eus-medisin-innsats-vi-gjorde-det-som-matte-gjores/ 2025-06-25T07:55:29+00:00 https://www.lmi.no/2025/06/25/samme-medisin-ulik-konklusjon-derfor-ble-hartap-behandling-godkjent-i-danmark-men-avvist-i-norge/ 2025-06-25T07:56:30+00:00 https://www.lmi.no/2025/06/25/trumps-planer-kan-oke-legemiddelprisene-i-europa/ 2025-06-25T07:57:43+00:00 https://www.lmi.no/2025/06/25/bruker-sjelden-unntaksregel-anbefaler-legemiddel-til-bruk-ved-atomulykker/ 2025-06-25T07:58:52+00:00 https://www.lmi.no/2025/06/25/navamedic-inn-i-nytt-marked-vil-kjope-norsk-selskap-for-225-millioner-kroner/ 2025-06-25T07:59:43+00:00 https://www.lmi.no/2025/06/25/novo-nordisk-avslutter-samarbeidet-med-amerikansk-partner/ 2025-06-25T08:00:34+00:00 https://www.lmi.no/2025/06/25/gar-fra-sykehusinnkjop-til-departementet/ 2025-06-25T08:01:24+00:00 https://www.lmi.no/2025/06/25/bekymrede-investorer-etter-masseoppsigelser-i-amerikansk-vaksinekomite/ 2025-06-25T08:02:25+00:00 https://www.lmi.no/2025/06/25/sarclisa-godkjent-som-forstelinjebehandling-av-myelomatose-ny-ema-anbefaling-kan-utvide-bruken-ytterligere/ 2025-06-25T08:03:27+00:00 https://www.lmi.no/2025/06/25/hadean-ventures-henter-partner-fra-novo-nordisk/ 2025-06-25T08:04:16+00:00 https://www.lmi.no/2025/06/25/forsker-pa-ultrasjelden-leukemi-kanskje-bare-en-nordmann-som-rammes-i-aret/ 2025-06-25T08:05:15+00:00 https://www.lmi.no/2025/06/25/exact-therapeutics-starter-behandling-i-internasjonal-kreftstudie/ 2025-06-25T08:06:12+00:00 https://www.lmi.no/2025/03/13/lmi-og-medlemmer-pa-scenen-under-frisk-fisk/ 2025-06-25T09:22:21+00:00 https://www.lmi.no/wp-content/uploads/2025/03/Monica-scenen-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/03/Monica-scenen-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/03/MSD-AH-Niels-Petter-Maaseide-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/03/MSD-AH-Lene-Hogset-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/03/Pharmaq-Anette-Furevik-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/03/Pharmaq-Rolf-Hetleid-Olsen-kopi.jpg https://www.lmi.no/2025/06/26/lmis-fiskehelseside-i-ny-drakt/ 2025-06-26T09:13:19+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Fiskehelsesiden.png https://www.lmi.no/wp-content/uploads/2025/06/Fiskehelsesiden.png https://www.lmi.no/wp-content/uploads/2025/06/Meny-fiskehelse.png https://www.lmi.no/2025/06/26/cathrine-58-fikk-dramatisk-diagnose-%e2%81%a0-jeg-sto-der-med-haret-i-hendene/ 2025-06-26T10:21:15+00:00 https://www.lmi.no/2025/06/26/kraftig-okning-i-nye-tilfeller-av-demens/ 2025-06-26T10:22:06+00:00 https://www.lmi.no/2025/06/26/ny-studie-spesifikk-detalj-ved-sovnen-din-kan-vaere-knyttet-til-rask-aldring-og-tidlig-dod/ 2025-06-26T10:23:20+00:00 https://www.lmi.no/2025/06/26/analyse-eli-lilly-vil-dominere-legemiddelsalget-i-2030/ 2025-06-26T10:24:28+00:00 https://www.lmi.no/2025/06/26/ingen-forskjell-i-overlevelse-mellom-immunterapier-mot-lungekreft/ 2025-06-26T10:25:22+00:00 https://www.lmi.no/2025/06/26/sveinung-stensland-blir-myndighetskontakt-i-eli-lilly/ 2025-06-26T10:26:14+00:00 https://www.lmi.no/2025/06/27/sveinung-stensland-til-eli-lilly-far-ansvar-for-nordisk-legemiddelpolitikk/ 2025-06-27T08:34:44+00:00 https://www.lmi.no/2025/06/27/sterke-reaksjoner-fra-pressen-na-legger-dmp-seg-flate/ 2025-06-27T08:35:55+00:00 https://www.lmi.no/2025/06/27/full-jubel-har-nadd-prestisjemal/ 2025-06-27T08:37:46+00:00 https://www.lmi.no/2025/06/27/eu-vil-skape-ny-handelsorganisasjon-wto-fungerer-ikke-lenger/ 2025-06-27T08:38:53+00:00 https://www.lmi.no/2025/06/27/pfizer-med-lovende-fase-3-resultater-for-hemofili-kandidat/ 2025-06-27T08:39:52+00:00 https://www.lmi.no/2025/06/27/helsevalget-2025-bard-hoksrud-frp-vi-far-faerre-ufore-med-mer-penger-til-helse-og-legemidler/ 2025-06-27T08:43:02+00:00 https://www.lmi.no/2025/06/27/msd-animal-health-norge-fikk-et-omsetningsloft-pa-over-200-millioner-kroner/ 2025-06-27T08:44:03+00:00 https://www.lmi.no/2025/06/27/storaksjon-avdekket-smugling-av-falske-legemidler/ 2025-06-27T08:44:57+00:00 https://www.lmi.no/2025/06/27/vi-bruker-det-samme-regelverket-som-de-som-produserer-legemidler-til-mennesker/ 2025-06-27T08:46:38+00:00 https://www.lmi.no/2025/06/27/syk-fisk-er-ikke-baerekraftig/ 2025-06-27T10:39:50+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Dafydd-Morris-2_edited-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/06/Dafydd-Morris-2_edited-scaled.jpg https://www.lmi.no/2025/06/30/softox-solutions-henter-biotekprofil-til-styret/ 2025-06-30T08:07:36+00:00 https://www.lmi.no/2025/06/30/tolletaten-og-dmp-avdekket-smugling-av-falske-fedmelegemidler/ 2025-06-30T08:08:25+00:00 https://www.lmi.no/2025/06/30/store-vi-ma-vaere-forberedt-pa-at-usa-gjennomforer-tollokninger-mot-norge-fra-9-juli/ 2025-06-30T08:09:09+00:00 https://www.lmi.no/2025/06/30/gikk-fra-rullestol-til-full-jobb/ 2025-06-30T08:10:16+00:00 https://www.lmi.no/2025/06/30/nye-funn-om-slankemedisin-sa-fort-kommer-kiloene-tilbake/ 2025-06-30T08:11:46+00:00 https://www.lmi.no/2025/06/30/ny-studie-spesiell-behandling-kan-gi-hap-om-et-liv-uten-insulin-for-en-gruppe-diabetikere/ 2025-06-30T08:13:46+00:00 https://www.lmi.no/2025/07/04/digitalis-tar-sommerferie-2/ 2025-07-04T07:00:00+00:00 https://www.lmi.no/wp-content/uploads/2025/06/An-illustration-showing-a-communication-team-on-summer-vacation.jpg https://www.lmi.no/wp-content/uploads/2025/06/An-illustration-showing-a-communication-team-on-summer-vacation.jpg https://www.lmi.no/2025/06/30/video-hvorfor-er-utprovende-behandling-viktig/ 2025-06-30T09:27:06+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Hvorfor-er-utprovende-behandling-viktig.png https://www.lmi.no/2025/06/30/video-hvordan-blir-et-legemiddel-egentlig-til/ 2025-06-30T10:03:06+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Hvordan-blir-et-legemiddel-egentlig-til.png https://www.lmi.no/2025/06/30/norsk-delegasjon-til-japan-for-a-utveksle-radiofarmasi-ekspertise/ 2025-06-30T11:49:21+00:00 https://www.lmi.no/wp-content/uploads/2025/06/Japan_Norsk-delegasjon-utenfor-Nordisk-paviljong-scaled-e1751280174860.jpeg https://www.lmi.no/wp-content/uploads/2025/06/Japan_Norsk-delegasjon-utenfor-Nordisk-paviljong-scaled-e1751280174860.jpeg https://www.lmi.no/wp-content/uploads/2025/06/Japan_rundebordsmote.jpg https://www.lmi.no/wp-content/uploads/2025/06/Japan_Nordic-Health-D.jpg https://www.lmi.no/wp-content/uploads/2025/06/Japan_Expo2025-Nordic-Mission.jpg https://www.lmi.no/wp-content/uploads/2025/06/Japan_delegasjonen.jpg https://www.lmi.no/wp-content/uploads/2025/06/Japan_Norsk-delegasjon-pa-National-Institutes-for-Quantum-Science-and-Technology-QST-e1751280607637.jpeg https://www.lmi.no/wp-content/uploads/2025/06/Japan_EXPO2025.jpg https://www.lmi.no/wp-content/uploads/2025/06/Japan_Norsk-ambassador-til-Japan-Kristin-Iglum-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/06/Japan_LMIs-Monica-Larsen-under-Nordic-Health-Days-pa-EXPO-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/06/Japan_Masaki-JRPA.jpg https://www.lmi.no/2019/06/29/2174/ 2025-06-30T13:12:19+00:00 https://www.lmi.no/wp-content/uploads/2016/06/Offentliggj%C3%B8ring-av-verdioverf%C3%B8ringer.gif https://www.lmi.no/wp-content/uploads/2016/07/AbbVie-e1470056703396.png https://www.lmi.no/wp-content/uploads/2016/06/AMG_Amg_Blu.png https://www.lmi.no/wp-content/uploads/2016/06/astellas.png https://www.lmi.no/wp-content/uploads/2016/06/astrazeneca.png https://www.lmi.no/wp-content/uploads/2016/06/Bayer.png https://www.lmi.no/wp-content/uploads/2016/06/Biogen.png https://www.lmi.no/wp-content/uploads/2018/08/BASFo_bl100tr_ct.png https://www.lmi.no/wp-content/uploads/2016/06/Boehringer_logo.png https://www.lmi.no/wp-content/uploads/2025/03/bms_logo_300_rgb_pos.original.png https://www.lmi.no/wp-content/uploads/2021/07/Chiesi-Logo-Primary-RGB_2.png https://www.lmi.no/wp-content/uploads/2016/07/Eisai-Symbol-color_2009.png https://www.lmi.no/wp-content/uploads/2016/07/Lilly.png https://www.lmi.no/wp-content/uploads/2016/07/Fresenius.png https://www.lmi.no/wp-content/uploads/2016/07/GE-Healthcare.png https://www.lmi.no/wp-content/uploads/2023/01/ny-GSK.png https://www.lmi.no/wp-content/uploads/2024/09/istituto-gentili-srl-logo-vector.png https://www.lmi.no/wp-content/uploads/2019/06/image-1.png https://www.lmi.no/wp-content/uploads/2016/06/Logo_of_Leo_Pharma.png https://www.lmi.no/wp-content/uploads/2016/06/Lundbeck_Logo_rgb300-hoy-oppl.png https://www.lmi.no/wp-content/uploads/2016/07/Merck-LOGO-2015-TURKIS-10mm-eps.png https://www.lmi.no/wp-content/uploads/2016/07/Novartis.png https://www.lmi.no/wp-content/uploads/2021/06/11nn_logo_cmyk_blue_small.png https://www.lmi.no/wp-content/uploads/2024/06/MSD-300x113-1.png https://www.lmi.no/wp-content/uploads/2016/07/otsuka-logo.png https://www.lmi.no/wp-content/uploads/2023/09/Pfizer_Logo_Color_CMYK.png https://www.lmi.no/wp-content/uploads/2019/02/Navamedic-logo.png https://www.lmi.no/wp-content/uploads/2016/08/Roche_Logo.svg.png https://www.lmi.no/wp-content/uploads/2024/07/Logo-Sanofi-550x254-1.png https://www.lmi.no/wp-content/uploads/2016/08/Servier_company_logo.png https://www.lmi.no/wp-content/uploads/2019/06/image-2.png https://www.lmi.no/wp-content/uploads/2016/06/Logo_Takeda.png https://www.lmi.no/wp-content/uploads/2016/08/UCB.png https://www.lmi.no/wp-content/uploads/2018/09/US_Viatris_Logo_Horiz_RGB_BLUE.png https://www.lmi.no/wp-content/uploads/2018/02/PFPN-LOGO.png https://www.lmi.no/wp-content/uploads/2019/02/Daiichi-Sankyo.jpg https://www.lmi.no/wp-content/uploads/2024/06/BioArctic-Logotyp-1.jpg https://www.lmi.no/2025/07/01/oncoinvent-og-bergenbio-vil-sla-seg-sammen/ 2025-07-01T10:20:19+00:00 https://www.lmi.no/2025/07/01/navamedic-far-gront-lys-for-medisinsk-utstyr-som-doserer-parkinson-tabletter/ 2025-07-01T10:21:56+00:00 https://www.lmi.no/2025/07/01/ny-norsk-radiofarmasi-kjempe-fjerner-mye-risiko/ 2025-07-01T10:22:51+00:00 https://www.lmi.no/2025/07/01/dette-er-de-ti-best-betalte-legemiddelsjefene-i-big-pharma/ 2025-07-01T10:23:37+00:00 https://www.lmi.no/2025/07/01/imbruvica-kan-erstatte-transplantasjon-norske-leger-soker-tidlig-bruk/ 2025-07-01T10:25:57+00:00 https://www.lmi.no/2025/07/01/kinesiske-innovent-utfordrer-novo-nordisk-og-eli-lilly-med-ny-fedmemedisin/ 2025-07-01T10:28:06+00:00 https://www.lmi.no/2025/07/01/truqap-avslag-skaper-reaksjoner-vurderingen-gjenspeiler-ikke-norsk-virkelighet/ 2025-07-01T10:28:59+00:00 https://www.lmi.no/2025/07/01/astrazeneca-truqap-vurderingen-tar-ikke-hensyn-til-norsk-praksis/ 2025-07-01T10:29:44+00:00 https://www.lmi.no/2025/07/01/handlingsrommet-fra-venting-til-handling/ 2025-07-01T12:23:36+00:00 https://www.lmi.no/2025/07/01/norsk-helsenaering-fra-mulighet-til-virkelighet/ 2025-07-01T12:26:26+00:00 https://www.lmi.no/2025/07/01/vaksiner-horer-med-i-totalberedskapen/ 2025-07-01T12:43:33+00:00 https://www.lmi.no/2025/07/02/faerre-royker-men-flere-far-lungekreft-na-peker-studie-peker-pa-en-ting-som-gir-oss-den-vanlige-kreftformen/ 2025-07-02T09:33:14+00:00 https://www.lmi.no/2025/07/02/novo-nordisk-har-valgt-hodejeger-til-toppsjef-jakten/ 2025-07-02T09:34:41+00:00 https://www.lmi.no/2025/07/02/hemispherian-far-saerstatus-i-usa-for-behandling-av-hjernekreft/ 2025-07-02T09:36:05+00:00 https://www.lmi.no/2025/07/02/bayers-oyelegemiddel-godkjent-for-sjeldnere-behandling/ 2025-07-02T09:37:33+00:00 https://www.lmi.no/2025/07/02/signum-kjoper-seg-inn-i-farmastat/ 2025-07-02T12:42:28+00:00 https://www.lmi.no/wp-content/uploads/2025/07/Leif-Rune-Skymoen-og-Ida-Sofie-Jensen-handshake.jpg https://www.lmi.no/wp-content/uploads/2025/07/Signering-Leif-Rune-Skymoen-og-Ida-Sofie-Jensen-ser-opp.jpg https://www.lmi.no/wp-content/uploads/2025/07/Signering-Leif-Rune-Skymoen-og-Ida-Sofie-Jensen.jpg https://www.lmi.no/wp-content/uploads/2025/07/Leif-Rune-Skymoen-og-Ida-Sofie-Jensen-handshake.jpg https://www.lmi.no/2025/06/30/lmi-i-arendalsuka-2025-2/ 2025-07-03T08:13:12+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Arendalsuka-ute-3-1-1280x960-1.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-20-scaled.jpg https://www.lmi.no/2025/07/03/lmi-i-altinget-justering-av-alternativkostnaden-ma-skje-i-trad-med-stortingets-intensjon/ 2025-07-03T08:36:12+00:00 https://www.lmi.no/wp-content/uploads/2025/07/Altinget-altkost.png https://www.lmi.no/wp-content/uploads/2025/07/Altinget-altkost.png https://www.lmi.no/2025/07/03/lmi-selger-farmastat-bytter-navn-til-signum/ 2025-07-03T08:46:41+00:00 https://www.lmi.no/2025/07/03/curida-star-med-apne-armer-men-staten-star-stille/ 2025-07-03T08:48:32+00:00 https://www.lmi.no/2025/07/03/softox-solutions-henter-biotekprofil-til-styret-2/ 2025-07-03T08:49:17+00:00 https://www.lmi.no/2025/07/03/usa-fjerner-sikkerhetsprogram-for-car-t/ 2025-07-03T08:49:58+00:00 https://www.lmi.no/2025/07/03/mange-slutter-for-tidlig-med-slankemedisin-mener-forskere/ 2025-07-03T08:50:54+00:00 https://www.lmi.no/2025/07/03/en-uke-til-trumps-tollpause-er-over/ 2025-07-03T08:52:12+00:00 https://www.lmi.no/2025/07/03/halvarlige-sproyter-kan-gi-ny-hverdag-for-pasienter-med-alvorlige-oyesykdommer/ 2025-07-03T08:52:59+00:00 https://www.lmi.no/2025/07/03/britisk-avis-astra-zeneca-vurderer-a-flytte-borsnoteringen-til-usa/ 2025-07-03T08:54:15+00:00 https://www.lmi.no/2025/07/03/bergensbedriften-msd-animal-health-innovation-as-topper-listen-i-norge/ 2025-07-03T08:55:22+00:00 https://www.lmi.no/2025/07/03/debatt-justering-av-alternativkostnaden-ma-skje-i-trad-med-stortingets-intensjon/ 2025-07-03T08:56:14+00:00 https://www.lmi.no/2025/07/01/lmi-i-arendalsuka-2025/ 2025-07-03T09:16:04+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Arendalsuka-ute-3-1-1280x960-1.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-67-scaled.jpg https://www.lmi.no/2025/07/04/bergenbio-og-oncoinvent-vil-bli-ett-selskap-skal-hente-130-nye-millioner/ 2025-07-04T08:26:45+00:00 https://www.lmi.no/2025/07/04/oversikt-dette-er-eus-livsvitenskap-strategi/ 2025-07-04T08:27:31+00:00 https://www.lmi.no/2025/07/04/reduserte-alkoholforbruketved-a-kombinere-legemidler/ 2025-07-04T08:29:22+00:00 https://www.lmi.no/2025/07/04/rsv-vaksine-til-vurdering-i-to-ar-legemiddelselskap-advarer-mot-utsettelse/ 2025-07-04T08:30:26+00:00 https://www.lmi.no/2025/07/04/dmp-forventer-at-metodevurdering-av-rsv-vaksine-er-klar-til-hosten/ 2025-07-04T08:31:21+00:00 https://www.lmi.no/2025/07/04/hod-vil-vente-pa-utredning-for-vaksineavgjorelse/ 2025-07-04T08:32:08+00:00 https://www.lmi.no/2025/07/28/e24-raser-mot-systemet-pasienter-lider-og-dor/ 2025-07-28T08:45:38+00:00 https://www.lmi.no/wp-content/uploads/2025/07/Skjermbilde-2025-07-28-103219.png https://www.lmi.no/wp-content/uploads/2025/07/Skjermbilde-2025-07-28-103219.png https://www.lmi.no/2025/07/21/raser-mot-systemet-pasienter-lider-og-dor/ 2025-07-28T10:13:24+00:00 https://www.lmi.no/2024/01/17/uten-fiskevaksiner-ingen-oppdrettslaks/ 2025-08-03T20:01:58+00:00 https://www.lmi.no/wp-content/uploads/2023/09/66A2352-scaled.jpg https://www.lmi.no/2025/08/04/novo-nordisk-smell-kan-ramme-dansk-okonomi-det-er-sa-enkelt-som-det/ 2025-08-04T10:39:04+00:00 https://www.lmi.no/2025/08/04/sverige-utreder-ny-lov-om-legemiddelmangel/ 2025-08-04T10:41:33+00:00 https://www.lmi.no/2025/08/04/listhaug-lanserer-10-punktsplan-for-helsevesenet-vil-ha-handa-pa-rattet/ 2025-08-04T10:54:32+00:00 https://www.lmi.no/2025/08/04/moderna-kutter-10-prosent-av-arbeidsstyrken-et-vanskelig-men-nodvendig-grep/ 2025-08-04T10:55:32+00:00 https://www.lmi.no/2025/08/04/skuffer-med-hjerte-kar-studie/ 2025-08-04T10:56:49+00:00 https://www.lmi.no/2025/08/04/gsk-far-eu-godkjenning-for-blenrep-kan-bli-ny-standard-i-behandlingen-av-benmargskreft/ 2025-08-04T10:57:39+00:00 https://www.lmi.no/2025/08/05/referat-fra-kontaktmote-mellom-lmi-og-hod-2/ 2025-08-05T09:09:21+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Referat_rapport_sporreskjema_AdobeStock_-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/08/Referat_rapport_sporreskjema_AdobeStock_-scaled.jpeg https://www.lmi.no/2025/08/06/mener-kosttilskudd-kan-gi-bedre-humor-pa-bare-to-uker/ 2025-08-06T10:26:45+00:00 https://www.lmi.no/2025/08/06/apotekteknikernes-nye-hverdag/ 2025-08-06T10:28:30+00:00 https://www.lmi.no/2025/08/06/trump-varsler-toll-pa-databrikker-og-medisiner-innen-neste-uke-eller-noe/ 2025-08-06T10:46:11+00:00 https://www.lmi.no/2025/08/06/sjokkfunn-om-kortison-advarer/ 2025-08-06T10:49:18+00:00 https://www.lmi.no/2025/08/06/ost-timors-malaria-mirakel-fra-220-000-til-null-tilfeller/ 2025-08-06T10:53:45+00:00 https://www.lmi.no/2025/08/06/vil-bedre-tilgangen-for-sjelden-pasienter-frp-vurderer-fondslosning/ 2025-08-06T11:10:47+00:00 https://www.lmi.no/2025/08/06/abbvie-med-sterke-resultater-for-rinvoq-i-behandling-av-alvorlig-alopecia-areata/ 2025-08-06T11:14:20+00:00 https://www.lmi.no/2025/08/06/novo-nordisk-tjente-537-milliarder-kroner-i-andre-kvartal/ 2025-08-06T11:15:17+00:00 https://www.lmi.no/2025/08/05/horing-endring-i-blareseptforskriften-beregning-av-egenandel/ 2025-08-06T11:21:26+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2025/08/Apotek_legemiddel_medisin_-AdobeStock-scaled.jpeg https://www.lmi.no/2025/08/07/norgesgruppen-kjoper-seg-inn-i-apotekmarkedet/ 2025-08-07T08:40:26+00:00 https://www.lmi.no/2025/08/07/amerikansk-vaksine-kutt-legger-press-pa-europeiske-legemiddelaksjer/ 2025-08-07T08:41:31+00:00 https://www.lmi.no/2025/08/07/pfizer-overgikk-forventningene/ 2025-08-07T08:42:49+00:00 https://www.lmi.no/2025/08/07/avtroppende-konsernsjef-vil-trolig-komme-flere-oppsigelser-i-novo-nordisk-fremover/ 2025-08-07T08:44:04+00:00 https://www.lmi.no/2025/08/07/novartis-oyner-oppkjop-av-amerikansk-biotekselskap/ 2025-08-07T08:45:27+00:00 https://www.lmi.no/2025/08/07/generelle-budskap-geopolitisk-situasjon/ 2025-08-07T10:20:58+00:00 https://www.lmi.no/2025/07/01/budskap-arendalsuka-2025/ 2025-08-07T10:22:36+00:00 https://www.lmi.no/wp-content/uploads/2024/11/LMI-Venterommet-53-scaled.jpg https://www.lmi.no/2025/08/04/lmi-i-media-gjennom-sommeren/ 2025-08-08T07:39:52+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Collage-mediesaker-sommeren-2025.png https://www.lmi.no/wp-content/uploads/2025/08/Collage-mediesaker-sommeren-2025.png https://www.lmi.no/2025/08/08/kjoper-over-350-apotek-far-kritikk/ 2025-08-08T10:17:24+00:00 https://www.lmi.no/2025/08/08/novo-nordisk-fest-etter-studiesmell-for-konkurrenten/ 2025-08-08T10:18:40+00:00 https://www.lmi.no/2025/08/08/slar-alarm-norge-knuses-av-danmark-og-sverige/ 2025-08-08T10:20:33+00:00 https://www.lmi.no/2025/08/08/novo-nordisks-utslipp-oker-kraftig-i-forste-halvar/ 2025-08-08T10:21:36+00:00 https://www.lmi.no/2025/08/08/den-nye-novo-nordisk-toppsjefen-avviser-ikke-oppsigelsesrunde/ 2025-08-08T10:23:02+00:00 https://www.lmi.no/2025/08/08/england-satser-pa-en-baerekraftig-helsetjeneste/ 2025-08-08T10:34:20+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Fit-for-the-future-ill.png https://www.lmi.no/wp-content/uploads/2025/08/Fit-for-the-future-ill.png https://www.lmi.no/2025/08/14/en-ny-als-medisin-skal-proves-ut-i-norge-kjartan-hovgaard-gjor-alt-han-kan-for-a-fa-den/ 2025-08-14T18:41:51+00:00 https://www.lmi.no/2025/08/14/flere-far-hjertesvikt-verre-enn-kreft/ 2025-08-14T18:42:43+00:00 https://www.lmi.no/2025/08/14/ny-studie-slankemedisin-kan-bremse-aldring/ 2025-08-14T18:43:45+00:00 https://www.lmi.no/2025/08/14/milliardtap-i-dansk-pensjon-etter-novo-nordisk-kollaps/ 2025-08-14T18:45:01+00:00 https://www.lmi.no/2025/08/14/tepkinly-viser-lovende-resultater-i-fase-3-studie-for-follikulaert-lymfom/ 2025-08-14T18:46:02+00:00 https://www.lmi.no/2025/08/14/dmp-forbereder-seg-pa-medikamentbolge/ 2025-08-14T18:48:26+00:00 https://www.lmi.no/2025/08/14/novartis-aksjen-stiger-etter-positive-kliniske-resultater/ 2025-08-14T18:49:23+00:00 https://www.lmi.no/2025/08/14/storbritannia-lytter-til-usa-vil-bruke-mer-penger-pa-legemidler/ 2025-08-14T18:50:21+00:00 https://www.lmi.no/2025/08/14/samlet-toppledere-til-hemmelig-mote-i-arendal-slik-vil-de-styrke-norsk-livsvitenskap/ 2025-08-14T18:51:47+00:00 https://www.lmi.no/2025/08/14/gir-resept-pa-slankesproyte-uten-a-mote-pasienten-sterkt-kritisk/ 2025-08-14T18:52:57+00:00 https://www.lmi.no/2025/08/14/legemiddelmangel-advarer-mot-a-handle-forhastet-etter-eu-rapport/ 2025-08-14T18:55:10+00:00 https://www.lmi.no/2025/08/14/bayer-i-milliardavtale-om-ny-kreftkandidat/ 2025-08-14T18:56:01+00:00 https://www.lmi.no/2025/08/14/novo-nordisk-eli-lilly-og-pfizer-vil-inn-i-kinesisk-helseforsikring/ 2025-08-14T18:59:19+00:00 https://www.lmi.no/2025/08/14/arendalsuka-2025-vaksiner-er-viktig-for-totalforsvaret/ 2025-08-15T14:29:42+00:00 https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-33-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-33-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-36-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-45-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-61-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-67-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-85-scaled.jpg https://www.lmi.no/2025/08/15/arendalsuka-i-bilder-2/ 2025-08-16T15:27:26+00:00 https://www.lmi.no/wp-content/uploads/2025/08/arendalsuka-AN-9-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-9-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-19-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-23-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-33-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-45-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-67-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-61-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/vaksine-AN-79-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-23-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-28-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-74-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-57-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-50-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-96-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-44-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-5-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-84-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-11-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-6-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-30-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-39-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-14-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-45-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-72-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-31-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-6-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-28-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-35-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-39-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-67-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-53-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-75-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-100-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-108-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-86-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-103-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/mingling-AN-116-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/panel-AN-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/panel-AN-14-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/panel-AN-16-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Kronikermotet-3-Arendal2025_edited-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Kronikermotet-2-Arendal2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Fremtidens-kreftbehandling-Arendal2025-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/kvinnehelse-AN-17-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/kvinnehelse-AN-9-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/kvinnehelse-AN-46-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/diabetes-AN-35-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/diabetes-AN-10-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/diabetes-AN-40-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/nevro-AN-80-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/nevro-AN-90-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/nevro-AN-47-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/bio-AN-15-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/IMG_0443-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/IMG_0488.jpg https://www.lmi.no/wp-content/uploads/2025/08/processed-C9D14634-44BE-46E0-82A3-9AC32578CAD6.jpeg https://www.lmi.no/wp-content/uploads/2025/08/IMG_4802-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Image-5-1.jpg https://www.lmi.no/2025/08/18/ai-har-skapt-ny-antibiotika-mot-superbakterier/ 2025-08-18T10:09:25+00:00 https://www.lmi.no/2025/08/18/navamedic-lanserer-parkinson-produkt-i-oktober/ 2025-08-18T10:11:25+00:00 https://www.lmi.no/2025/08/18/kombinasjonsbehandling-gir-bedre-overlevelse-ved-blaerekreft/ 2025-08-18T10:14:24+00:00 https://www.lmi.no/2025/08/18/sveits-regjering-innkalte-legemiddeltopper-til-tollmote/ 2025-08-18T10:15:27+00:00 https://www.lmi.no/2025/08/18/eli-lilly-strekker-ut-en-hand-til-trump-forventer-a-justere-priser/ 2025-08-18T10:17:13+00:00 https://www.lmi.no/2025/08/18/her-kan-det-bli-paracet-monopol/ 2025-08-18T10:18:51+00:00 https://www.lmi.no/2025/08/18/dnb-sjefen-advarer-om-forholdet-til-eu-hoy-irritasjon/ 2025-08-18T10:25:52+00:00 https://www.lmi.no/2025/08/18/hver-tiende-danske-har-kjopt-novo-nordisk-aksjer-etter-nedtur/ 2025-08-18T10:26:41+00:00 https://www.lmi.no/2025/08/18/forskningsverden-ser-mot-danmark-etter-eventyrlig-suksess-med-slankemedisin/ 2025-08-18T10:27:46+00:00 https://www.lmi.no/2025/08/18/debatt-om-tilgang-med-hoy-temperatur/ 2025-08-18T11:14:33+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Handlingsrommet-Arendal-2025.jpg https://www.lmi.no/wp-content/uploads/2025/08/Handlingsrommet-Arendal-2025.jpg https://www.lmi.no/2025/08/20/savner-tunge-eksport-insentiver-fra-regjeringen-jeg-trenger-ikke-hjelp-med-markedsforingen/ 2025-08-20T08:16:59+00:00 https://www.lmi.no/2025/08/20/forsvaret-etterlyser-mer-samarbeid-med-legemiddelindustrien/ 2025-08-20T08:18:09+00:00 https://www.lmi.no/2025/08/20/eli-lilly-inngar-milliardavtale-med-ki-selskap/ 2025-08-20T08:19:54+00:00 https://www.lmi.no/2025/08/20/eli-lilly-varsler-okte-medisinpriser-i-europa/ 2025-08-20T08:20:52+00:00 https://www.lmi.no/2025/08/20/ni-har-sokt-tre-har-fatt-medisin-som-beslutningsforum-har-sagt-nei-til/ 2025-08-20T08:21:59+00:00 https://www.lmi.no/2025/08/20/penicillin-tilfeldig-oppdagelse-reddet-200-millioner-liv/ 2025-08-20T08:23:09+00:00 https://www.lmi.no/2025/08/20/vekttapspille-fra-amerikansk-biotekselskap-skuffer-i-fase-2/ 2025-08-20T08:23:59+00:00 https://www.lmi.no/2025/08/20/naer-9-av-10-soknader-om-wegovy-pa-bla-resept-far-avslag-fagfolk-klor-seg-i-hodet/ 2025-08-20T08:25:09+00:00 https://www.lmi.no/2025/08/20/risikerer-at-mellom-2000-og-4000-spedbarn-unodvendig-blir-lagt-inn-pa-sykehus/ 2025-08-20T08:26:05+00:00 https://www.lmi.no/2025/08/20/hodepinetabletter-kan-skade-celleutviklingen-tidlig-i-svangerskapet/ 2025-08-20T08:27:02+00:00 https://www.lmi.no/2025/08/20/rsv-medisin-kan-hjelpe-spedbarn-vil-norge-vente-til-2027/ 2025-08-20T08:28:05+00:00 https://www.lmi.no/2025/08/20/debatt-norge-taper-forskningskapplopet/ 2025-08-20T08:29:36+00:00 https://www.lmi.no/2025/08/20/genentech-avbryter-enda-et-biotek-samarbeid/ 2025-08-20T08:30:48+00:00 https://www.lmi.no/2025/08/20/pci-biotech-avvikler-hovedprosjekt/ 2025-08-20T08:31:46+00:00 https://www.lmi.no/2025/08/19/innspillsmote-om-ny-handlingsplan-for-kliniske-studier-tid-er-det-som-avgjor-alt/ 2025-08-20T09:18:44+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Innspillsmote-HOD-3_edited_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Innspillsmote-HOD-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/Innspillsmote-HOD-3-scaled.jpg https://www.lmi.no/2025/08/21/parkinson-kan-helhetlige-nasjonale-retningslinjer-sikre-tidligere-identifisering-og-henvisning/ 2025-08-21T07:07:29+00:00 https://www.lmi.no/2025/08/21/bergenbio-direktoren-med-farvel-bioteknologi-krever-mot/ 2025-08-21T07:10:27+00:00 https://www.lmi.no/2025/08/21/norge-ma-vaere-med-og-bidra-et-snylteland-er-det-ingen-av-oss-som-onsker/ 2025-08-21T07:12:15+00:00 https://www.lmi.no/2025/08/21/bekeng-og-hoksrud-vi-blir-nok-aldri-enige/ 2025-08-21T07:15:42+00:00 https://www.lmi.no/2025/08/21/vil-at-norsk-laks-som-har-fatt-genmodifisert-for-skal-merkes-men-sier-ingenting-om-importkjottet/ 2025-08-21T07:23:08+00:00 https://www.lmi.no/2025/08/21/professor-tror-betalingsviljen-for-legemidler-vil-oke-etter-valget/ 2025-08-21T07:30:40+00:00 https://www.lmi.no/2025/08/21/kreftpasienter-venter-637-dager-pa-de-nyeste-legemidlene/ 2025-08-21T07:31:54+00:00 https://www.lmi.no/2025/08/21/bms-direktor-systemet-mister-gradvis-relevans-ar-for-ar/ 2025-08-21T07:33:11+00:00 https://www.lmi.no/2025/08/21/mange-krymper-sa-mye-som-10-cm-tre-grep-bremser-det/ 2025-08-21T07:33:56+00:00 https://www.lmi.no/2025/08/21/msd-satser-tungt-pa-teknologi-tilbakemeldingene-har-vaert-svaert-gode/ 2025-08-21T07:44:31+00:00 https://www.lmi.no/2025/08/21/akvafuture-og-oppdrettere-som-slutta-med-rensefisk-vant-pris-for-fiskevelferd/ 2025-08-21T07:48:12+00:00 https://www.lmi.no/2025/08/21/frokostseminar-om-helsedata-data-fra-primaerhelsetjenesten-2/ 2025-08-21T08:32:14+00:00 https://www.lmi.no/wp-content/uploads/2025/04/Legekontor-helsedata-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/04/Legekontor-helsedata-Adobe-Stock-scaled.jpeg https://www.lmi.no/2025/08/21/ueg-week-presenterer-norge-som-studieland-pa-gastro-feltet/ 2025-08-21T10:10:13+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Berlin_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/08/Berlin_AdobeStock-scaled.jpeg https://www.lmi.no/2025/08/22/ny-studie-om-alzheimer-%e2%81%a0-kan-ha-vesentlig-betydning/ 2025-08-22T09:32:53+00:00 https://www.lmi.no/2025/08/22/de-som-brukte-slankemedisin-ble-yngre-svaert-interessante-resultater/ 2025-08-22T09:34:19+00:00 https://www.lmi.no/2025/08/22/bms-direktor-systemet-mister-gradvis-relevans-ar-for-ar-2/ 2025-08-22T09:35:09+00:00 https://www.lmi.no/2025/08/22/nho-om-tollavtale-norske-bedrifter-far-darligere-vilkar-enn-europeiske-konkurrenter/ 2025-08-22T09:37:17+00:00 https://www.lmi.no/2025/08/22/usa-innforer-toll-pa-eu-legemidler/ 2025-08-22T09:39:55+00:00 https://www.lmi.no/2025/08/22/novo-nordisk-henter-medisinsk-direktor-fra-egne-rekker/ 2025-08-22T09:40:48+00:00 https://www.lmi.no/2025/08/22/kreftmedisiner-dominerer-neste-mote-i-beslutningsforum/ 2025-08-22T09:41:40+00:00 https://www.lmi.no/2025/08/22/programmet-for-regulatorisk-hostmote-2025-er-klart/ 2025-08-22T09:48:44+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Reg-hostmote-bilde-2025.jpg https://www.lmi.no/wp-content/uploads/2025/08/REgulatorisk-hostmote-2025_ill.png https://www.lmi.no/wp-content/uploads/2023/10/62B4A320-60EB-4331-B7FC-946F7F98C9E0-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/06/regulatorisk-hostmote-2021_linn-camilla-scaled.jpg https://www.lmi.no/2025/08/25/ingen-fisk-a-miste/ 2025-08-25T07:29:12+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Laks_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/08/Laks_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/08/Leslie_Dafydd_Lene-scaled.jpg https://www.lmi.no/2025/08/25/kreftmedisiner-dominerer-neste-mote-i-beslutningsforum-2/ 2025-08-25T08:44:57+00:00 https://www.lmi.no/2025/08/25/kan-et-mye-brukt-grunnstoff-hjelpe-mot-alzheimers-sykdom/ 2025-08-25T08:45:50+00:00 https://www.lmi.no/2025/08/25/usa-toll-kan-koste-europeiske-legemiddelselskaper-over-200-milliarder-kroner/ 2025-08-25T08:46:46+00:00 https://www.lmi.no/2025/08/25/seks-legemiddelselskaper-passerer-milliardgrensen-i-norge/ 2025-08-25T08:47:48+00:00 https://www.lmi.no/2025/08/25/medie-novo-nordisk-toppsjef-kutter-ansattbonus/ 2025-08-25T08:48:50+00:00 https://www.lmi.no/2025/08/25/storaksjonaer-selger-seg-helt-ut-av-pci-biotech/ 2025-08-25T08:49:42+00:00 https://www.lmi.no/2025/08/25/meld-deg-pa-hostens-reklamekurs-3/ 2025-08-25T09:30:11+00:00 https://www.lmi.no/wp-content/uploads/2019/08/Reklame_Dig_Nov-2019.jpg https://www.lmi.no/2025/08/26/beslutningsforum-sier-ja-til-ketamin-men-kritikken-hagler-norge-verdsetter-ikke-innovasjon/ 2025-08-26T08:12:04+00:00 https://www.lmi.no/2025/08/26/kisqali-godkjent-i-beslutningsforum-gir-nytt-tilbud-til-pasienter-med-tidlig-brystkreft-og-hoy-risiko-for-tilbakefall/ 2025-08-26T08:13:32+00:00 https://www.lmi.no/2025/08/26/beslutningsforum-innforer-ti-nye-kreftbehandlinger/ 2025-08-26T08:14:38+00:00 https://www.lmi.no/2025/08/26/idrettslegenda-hudfletta-etter-omstridd-reklame-ei-skam/ 2025-08-26T08:15:44+00:00 https://www.lmi.no/2025/08/26/bioarctic-tegner-millionavtale-med-novartis/ 2025-08-26T08:16:39+00:00 https://www.lmi.no/2025/08/26/dansk-studie-vekker-oppsikt-lovende/ 2025-08-26T08:17:35+00:00 https://www.lmi.no/2025/08/26/astrazeneca-fikk-dobbelt-ja-pa-blaerekreft-og-blodkreft/ 2025-08-26T08:18:39+00:00 https://www.lmi.no/2025/08/26/frykter-for-datteren-17-jeg-er-desperat/ 2025-08-26T08:19:32+00:00 https://www.lmi.no/2025/08/22/lmi-i-healthtalk-utfordrer-norges-omdomme/ 2025-08-27T09:05:29+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Off-label.png https://www.lmi.no/wp-content/uploads/2025/08/Off-label.png https://www.lmi.no/2025/08/27/meld-deg-pa-lmis-strategisamling/ 2025-08-27T09:23:33+00:00 https://www.lmi.no/wp-content/uploads/2019/10/St%C3%B8tvig.jpeg https://www.lmi.no/wp-content/uploads/2019/10/St%C3%B8tvig.jpeg https://www.lmi.no/2025/08/27/vestre-mislykkes-med-malene-for-kliniske-studier-ingen-dobling-og-pasientmalet-ryker/ 2025-08-27T10:00:27+00:00 https://www.lmi.no/2025/08/27/topp-forsker-fredrik-schjesvold-motvilje-i-ous-ledelsen-hemmer-kliniske-studier-i-norge/ 2025-08-27T10:28:37+00:00 https://www.lmi.no/2025/08/27/ous-avviser-schjesvolds-kritikk-om-motvilje-til-industrisamarbeid/ 2025-08-27T10:30:06+00:00 https://www.lmi.no/2025/08/27/dmp-avviser-kritikk-ingen-motvilje-mot-industrisamarbeid/ 2025-08-27T10:31:08+00:00 https://www.lmi.no/2025/08/27/helsedirektoratet-innrommer-malbrist-ikke-fornoyd-med-utviklingen-i-kliniske-studier/ 2025-08-27T10:32:05+00:00 https://www.lmi.no/2025/08/27/sykehuset-gir-likevel-kreftpasient-behandling-jeg-er-utrolig-lettet/ 2025-08-27T10:33:07+00:00 https://www.lmi.no/2025/08/27/alzheimer-legemiddel-lanseres-i-eu/ 2025-08-27T10:34:15+00:00 https://www.lmi.no/2025/08/27/nykode-satser-alt-pa-kreftvaksinen-abi-suva/ 2025-08-27T10:35:21+00:00 https://www.lmi.no/2024/12/04/na-blir-det-engelskspraklige-fellesnordiske-legemiddelpakninger/ 2025-08-28T07:37:57+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Medisin-i-apotek_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/06/Medisin-i-apotek_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/12/Dag-Jordbru_foto-DMP.png https://www.lmi.no/wp-content/uploads/2023/11/Linn-Camilla-Svenningsen_portrett-scaled.jpg https://www.lmi.no/2025/08/28/dmp-pa-besok-hos-lmis-gruppe-for-regulatory-og-pharmacovigilance/ 2025-08-28T07:40:15+00:00 https://www.lmi.no/wp-content/uploads/2025/08/DMP-hos-regulatorisk-gruppe-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/DMP-hos-regulatorisk-gruppe-scaled.jpg https://www.lmi.no/2025/08/28/digitalt-medlemsmote-om-toll-og-mfn/ 2025-08-28T09:01:55+00:00 https://www.lmi.no/wp-content/uploads/2024/10/medlemsmote-scaled.jpg https://www.lmi.no/2025/08/28/dmp-endrer-prosessen-for-innsending-av-dokumentasjon-til-metodevurdering/ 2025-08-28T09:02:15+00:00 https://www.lmi.no/wp-content/uploads/2025/08/Skjermbilde-2025-08-28-100230.png https://www.lmi.no/2025/08/28/lofte-fra-helse-og-omsorgsministeren-tre-milliarder-arlig-til-investeringer-i-medisinsk-utstyr-og-teknologi/ 2025-08-28T09:19:28+00:00 https://www.lmi.no/2025/08/28/nye-funn-om-adhd-kobles-til-alvorlig-diagnose/ 2025-08-28T09:21:40+00:00 https://www.lmi.no/2025/08/28/medisinplante-pa-fortauskanten/ 2025-08-28T09:23:01+00:00 https://www.lmi.no/2025/08/28/frida-tok-dramatisk-valg-har-vondt-dognet-rundt/ 2025-08-28T09:28:05+00:00 https://www.lmi.no/2025/08/28/nhos-bonn-til-regjeringen-for-tollmote-kan-ikke-leve-med-darligere-vilkar/ 2025-08-28T09:29:18+00:00 https://www.lmi.no/2025/08/28/risikopasienter-blir-mer-sarbare-i-et-tregt-system/ 2025-08-28T10:12:10+00:00 https://www.lmi.no/2025/08/18/opptak-av-lmis-moter-under-arendalsuka/ 2025-08-28T10:12:55+00:00 https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-84-scaled.jpg https://www.lmi.no/2025/08/28/regjeringen-med-tipunktsplan-for-helsevesenet-vil-ha-faerre-kasteballer/ 2025-08-28T10:13:18+00:00 https://www.lmi.no/2025/08/28/styrker-forskningen-innen-nukleaermedisin/ 2025-08-28T10:16:21+00:00 https://www.lmi.no/2025/08/28/ny-hiv-behandling-godkjent-i-europa/ 2025-08-28T10:18:59+00:00 https://www.lmi.no/2025/08/14/arendalsuka-2025-vi-ma-torre-a-bruke-mer-penger-pa-helse/ 2025-08-28T10:21:09+00:00 https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-74-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-74-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-23-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-28-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-53-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/handling-AN-74-1-scaled.jpg https://www.lmi.no/2025/08/14/arendalsuka-2025-lovet-fempunktsliste-for-a-tiltrekke-investeringer/ 2025-08-28T10:21:51+00:00 https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-48-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/LifeScience-mote-Arendalsuka-2025.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-43-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-19-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-30-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/08/helse-AN-72-scaled.jpg https://www.lmi.no/2025/08/28/keytruda-effekt-for-lytix-biopharma-ti-millioner-kroner-spart/ 2025-08-28T10:27:18+00:00 https://www.lmi.no/2018/10/15/lmi-lanserer-e-laeringskurs-om-reklame/ 2025-08-29T08:08:13+00:00 https://www.lmi.no/wp-content/uploads/2016/06/E-l%C3%A6ring.jpg https://www.lmi.no/wp-content/uploads/2024/05/Elaering-illustrasjon-inni-sak.png https://www.lmi.no/2025/08/29/onsker-innspill-til-utredning-av-alternativkostnaden/ 2025-08-29T08:48:33+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-scaled.jpg https://www.lmi.no/2025/08/29/novo-nordisk-i-danmark-sier-opp-nyansatte-for-oppstart/ 2025-08-29T09:59:17+00:00 https://www.lmi.no/2025/08/29/kristin-svanqvist-skal-lede-nansen-neuroscience-network/ 2025-08-29T10:00:33+00:00 https://www.lmi.no/2025/08/29/ber-om-innspill-til-alternativkostnad-terskelverdien-under-lupen/ 2025-08-29T10:02:39+00:00 https://www.lmi.no/2025/08/29/ny-ordning-kan-gi-eli-lilly-forsprang-pa-novo-nordisk/ 2025-08-29T10:03:48+00:00 https://www.lmi.no/2025/08/29/thor-medical-har-gatt-fra-labprosjekt-til-fabrikk-pa-tre-ar-for-godt-til-a-vaere-sant/ 2025-08-29T10:05:22+00:00 https://www.lmi.no/2025/08/29/circio-peiler-seg-inn-mot-hjerte-og-oyelidelser/ 2025-08-29T10:06:33+00:00 https://www.lmi.no/2025/08/29/oncoinvent-og-thor-medical-inngar-avtale/ 2025-08-29T10:07:55+00:00 https://www.lmi.no/2025/08/29/redningsaksjon-ble-suksesshistorie-curida-fyller-ti-ar/ 2025-08-29T10:10:10+00:00 https://www.lmi.no/2025/08/29/na-er-e-laeringskurs-tilgjengelig-pa-engelsk/ 2025-08-29T12:01:35+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Elaering-illustrasjon-dig-forside.png https://www.lmi.no/wp-content/uploads/2025/08/Elaering-illustrasjon-inni-sak-2048x951-1.png https://www.lmi.no/2025/09/02/ny-medisin-kan-bli-et-gjennombrudd-i-behandlingen-av-hoyt-blodtrykk/ 2025-09-02T10:15:06+00:00 https://www.lmi.no/2025/09/02/novo-nordisks-fedmemedisin-overgar-eli-lillys-i-studie-om-hjerteinfarkt/ 2025-09-02T10:16:04+00:00 https://www.lmi.no/2025/09/02/kliniske-studier-malene-som-glapp/ 2025-09-02T10:17:49+00:00 https://www.lmi.no/2025/09/02/redningsaksjon-ble-suksesshistorie-vi-er-her-for-a-vokse/ 2025-09-02T10:18:40+00:00 https://www.lmi.no/2025/09/02/helsenaeringen-og-private-helseaktorer-utelatt-fra-nytt-utvalg-dette-reagerer-jeg-sterkt-pa/ 2025-09-02T10:19:40+00:00 https://www.lmi.no/2025/09/02/studie-vektreduserende-legemidler-ved-hjertesvikt-er-bra-for-miljoet-nytt-perspektiv/ 2025-09-02T10:20:36+00:00 https://www.lmi.no/2025/09/02/dette-mener-de-om-direktoratet-for-medisinske-produkter/ 2025-09-02T10:21:35+00:00 https://www.lmi.no/2025/09/02/tar-over-ansvaret-for-legemiddelvurdering-i-dmp/ 2025-09-02T10:22:32+00:00 https://www.lmi.no/2025/09/02/calluna-pharma-starter-fase-2-studie/ 2025-09-02T10:23:37+00:00 https://www.lmi.no/2025/09/02/novo-nordisk-har-fatt-ny-baerekraftsjef/ 2025-09-02T10:24:44+00:00 https://www.lmi.no/2025/09/02/astra-zeneca-ki-avgjorende-for-legemiddelutvikling/ 2025-09-02T10:25:34+00:00 https://www.lmi.no/2025/09/02/industri-og-klinikere-mottes-under-esc-kongressen-i-madrid-vis-deres-styrker-og-lever-raskt/ 2025-09-02T11:28:53+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Madridmote-1-1-scaled.jpeg https://www.lmi.no/wp-content/uploads/2025/09/Madrimote-4-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Madridmote-6-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Madridmote-1-1-scaled.jpeg https://www.lmi.no/2025/09/03/usas-helseminister-ba-vitenskapelig-tidsskrift-om-a-trekke-vaksine-studie/ 2025-09-03T10:22:42+00:00 https://www.lmi.no/2025/09/03/vanskelig-kontrollerbart-blodtrykk-medisiner-virker-ikke-hvis-man-ikke-tar-dem/ 2025-09-03T10:25:49+00:00 https://www.lmi.no/2025/09/03/studie-slankemedisin-med-effekt-pa-hjerteflimmer/ 2025-09-03T10:26:44+00:00 https://www.lmi.no/2025/09/03/alzheimer-medisin-far-godkjenning-i-usa-som-injeksjon/ 2025-09-03T10:27:40+00:00 https://www.lmi.no/2025/09/03/lytix-biopharma-tildeler-49-aksjeoppsjoner/ 2025-09-03T10:29:05+00:00 https://www.lmi.no/2025/09/03/ber-legemiddelselskaper-redegjore-for-vaksineresultater/ 2025-09-03T10:30:08+00:00 https://www.lmi.no/2025/09/03/curida-feiret-sin-egen-10-arsdag/ 2025-09-03T14:12:52+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Curida-sjefen-og-ordforeren.jpg https://www.lmi.no/wp-content/uploads/2025/09/Curida-sjefen-og-ordforeren.jpg https://www.lmi.no/wp-content/uploads/2025/09/Leif-Rune-og-Curida-sjefen.jpg https://www.lmi.no/wp-content/uploads/2025/09/Per-Thoresen-og-Curida-ansatt.jpg https://www.lmi.no/wp-content/uploads/2025/09/Curida-ansatte.jpg https://www.lmi.no/wp-content/uploads/2015/07/frontcurida.jpg https://www.lmi.no/2025/09/04/sjefen-for-dansk-legemiddelindustri-gar-av-etter-20-ar/ 2025-09-04T08:34:55+00:00 https://www.lmi.no/2025/09/04/mener-covid-vaksine-ga-migrene-ny-studie-ser-mulig-sammenheng/ 2025-09-04T08:35:46+00:00 https://www.lmi.no/2025/09/04/setter-barna-pa-slankesproyter-de-er-provekaniner/ 2025-09-04T08:36:44+00:00 https://www.lmi.no/2025/09/04/novartis-inngar-milliardavtale-om-ny-parkinson-behandling/ 2025-09-04T08:37:33+00:00 https://www.lmi.no/2025/09/04/ny-studie-wegovy-knyttes-til-lavere-hjertesykdomsrisiko-enn-mounjaro/ 2025-09-04T08:38:23+00:00 https://www.lmi.no/2025/09/04/nekter-a-gi-opp-etter-studie-smell/ 2025-09-04T08:39:22+00:00 https://www.lmi.no/2025/09/04/florida-vil-fjerne-alle-statlige-vaksinekrav-ogsa-i-skolen/ 2025-09-04T08:42:46+00:00 https://www.lmi.no/2025/09/04/astra-zeneca-vil-soke-om-godkjenning-av-blodtrykksmedisin/ 2025-09-04T08:51:03+00:00 https://www.lmi.no/2025/09/04/helsedata-er-roten-til-mye-godt/ 2025-09-04T11:17:20+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Helsedatafrokostmote-kommunehelsetjenesten-scaled.jpg https://www.lmi.no/wp-content/uploads/2025/09/Helsedatafrokostmote-kommunehelsetjenesten-scaled.jpg https://www.lmi.no/2025/09/04/horing-forslag-til-endringer-i-lua-forskriften-og-apotekforskriften/ 2025-09-04T12:07:47+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2025/09/05/medlemsmotet-om-mfn/ 2025-09-05T08:37:19+00:00 https://www.lmi.no/wp-content/uploads/2025/09/Medlemsmotet-MFN-front-kopi.jpg https://www.lmi.no/wp-content/uploads/2025/09/Medlemsmotet-MFN-front-kopi.jpg https://www.lmi.no/2025/09/05/lise-hadde-ett-onske-sa-skjedde-det-utenkelige/ 2025-09-05T09:21:10+00:00 https://www.lmi.no/2025/09/05/palla-pharma-snuser-pa-historisk-legemiddelproduksjon/ 2025-09-05T09:22:43+00:00 https://www.lmi.no/2025/09/05/perspektiver-pa-prioritering/ 2025-09-05T09:24:12+00:00 https://www.lmi.no/2025/09/05/pfizer-toppen-smigrer-med-nobelpris-og-lover-apenhet-etter-trump-utspill/ 2025-09-05T09:29:05+00:00 https://www.lmi.no/2025/09/05/roche-ut-mot-sammenslaing-av-refusjonskoder-mener-lavere-pris-kan-trumfe-ny-behandling/ 2025-09-05T09:30:20+00:00 https://www.lmi.no/2025/09/08/debatt-slankesproyter-til-barn-kan-vaere-et-farlig-eksperiment/ 2025-09-08T09:54:08+00:00 https://www.lmi.no/2025/09/08/fda-offentliggjor-legemiddelavslag/ 2025-09-08T09:55:00+00:00 https://www.lmi.no/2025/09/08/novo-nordisk-vil-bekjempe-matstoy-for-a-fa-folk-til-a-ga-ned-i-vekt/ 2025-09-08T09:56:28+00:00 https://www.lmi.no/2025/09/08/debatt-alternativkostnaden-ma-reflektere-alternativkostnaden/ 2025-09-08T09:57:31+00:00 https://www.lmi.no/2025/09/08/den-amerikanske-helseministeren-vil-knytte-tylenol-til-autisme/ 2025-09-08T09:58:26+00:00 https://www.lmi.no/2025/09/08/panodil-ibuprofen-eller-cbd-slik-virker-de-smertestillende-pillene/ 2025-09-08T09:59:16+00:00 https://www.lmi.no/2025/09/08/kraftig-stigning-i-ulovlig-salg-av-fedmemidler-ema-advarer/ 2025-09-08T10:00:22+00:00 https://www.lmi.no/2025/09/08/egen-arbeidsgruppe-for-arbeidet-med-alternativkostnaden/ 2025-09-08T11:17:27+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/2025/09/10/ny-pris-skal-hedre-fremragende-innsats-i-kliniske-studier/ 2025-09-10T07:34:59+00:00 https://www.lmi.no/2025/09/10/kreftforeningen-altfor-fa-far-hjelp-gjennom-unntaksordningen/ 2025-09-10T07:36:01+00:00 https://www.lmi.no/2025/09/10/astra-zeneca-bekrefter-resultater-for-lungekreftbehandling-i-ny-studie/ 2025-09-10T07:37:04+00:00 https://www.lmi.no/2025/09/10/legemiddelindustrien-ber-ap-sikre-rammevilkar/ 2025-09-10T07:39:22+00:00 https://www.lmi.no/2025/09/10/novartis-kjoper-amerikansk-biotekselskap-i-milliardhandel/ 2025-09-10T07:40:16+00:00 https://www.lmi.no/2025/09/10/morgan-stanley-advarer-mot-investeringer-i-europeisk-legemiddelindustri/ 2025-09-10T07:40:41+00:00 https://www.lmi.no/2025/09/10/endrede-anbefalinger-for-overvaking-av-blodverdier-ved-bruk-av-klozapin/ 2025-09-10T07:41:53+00:00 https://www.lmi.no/2025/09/10/lundbeck-legger-ned-kommersiell-avdeling-over-600-ansatte-berort/ 2025-09-10T07:42:47+00:00